PTK2
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
Y Sites Probabilities
Log-Odds: Y Sites / Y Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0MZ66 | Y24 | Sugiyama | SHTN1 KIAA1598 | sDEEKQLQLITsLKEQAIGEyEDLRAENQKTKEKCDKIRQE |
| A5A3E0 | Y1062 | Sugiyama | POTEF A26C1B | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCL_______ |
| A5A3E0 | Y940 | Sugiyama | POTEF A26C1B | ALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPEA |
| O00401 | Y256 | GPS6|EPSD | WASL | FDMCGIsEAQLKDRETSKVIyDFIEKTGGVEAVKNELRRQA |
| O00410 | Y820 | Sugiyama | IPO5 KPNB3 RANBP5 | KLEEHFKNQELRQVKRQDEDyDEQVEEsLQDEDDNDVyILT |
| O00469 | Y444 | Sugiyama | PLOD2 | LWSNFWGALSPDGYYARsEDyVDIVQGNRVGVWNVPYMANV |
| O15357 | Y1135 | Sugiyama | INPPL1 SHIP2 | SGDDRSCSVLQMAKTLSEVDyAPAGPARSALLPGPLELQPP |
| O43164 | Y63 | Sugiyama | PJA2 KIAA0438 RNF131 | VSFKPCMTRHERSLGRAGDDyEVLELDDVPKENssGssPLD |
| O43237 | Y184 | Sugiyama | DYNC1LI2 DNCLI2 LIC2 | KIPPEKMRELERKFVKDFQDyMEPEEGCQGsPQRRGPLtsG |
| O43314 | Y256 | Sugiyama | PPIP5K2 HISPPD1 KIAA0433 VIP2 | YEEFMPTDGTDVKVytVGPDyAHAEARKSPALDGKVERDSE |
| O43390 | Y376 | Sugiyama | HNRNPR HNRPR | ILEKSFSEFGKLERVKKLKDyAFVHFEDRGAAVKAMDEMNG |
| O43390 | Y434 | Sugiyama | HNRNPR HNRPR | KKRKERQAARQAsRstAyEDyyyHPPPRMPPPIRGRGRGGG |
| O43390 | Y435 | Sugiyama | HNRNPR HNRPR | KRKERQAARQAsRstAyEDyyyHPPPRMPPPIRGRGRGGGR |
| O43707 | Y212 | Sugiyama | ACTN4 | WKDGLAFNALIHRHRPELIEyDKLRKDDPVTNLNNAFEVAE |
| O43707 | Y265 | SIGNOR | ACTN4 | DIVNtARPDEKAIMTyVssFyHAFsGAQKAETAANRICKVL |
| O43707 | Y31 | SIGNOR | ACTN4 | yQyGPSSAGNGAGGGGSMGDyMAQEDDWDRDLLLDPAWEKQ |
| O43707 | Y4 | SIGNOR | ACTN4 | _________________MVDyHAANQSyQyGPSSAGNGAGG |
| O43719 | Y650 | Sugiyama | HTATSF1 | EEDtyEKVFDDEsDEKEDEEyADEKGLEAADKKAEEGDADE |
| O43823 | Y311 | Sugiyama | AKAP8 AKAP95 | RGFDRFGPDGTGRKRKQFQLyEEPDtKLARVDsEGDFsEND |
| O43852 | Y185 | Sugiyama | CALU | KDGDLIATKEEFtAFLHPEEyDyMKDIVVQEtMEDIDKNAD |
| O43852 | Y263 | Sugiyama | CALU | KNRDGKMDKEEtKDWILPsDyDHAEAEARHLVyEsDQNKDG |
| O43852 | Y47 | Sugiyama | CALU | RVHHEPQLsDKVHNDAQsFDyDHDAFLGAEEAKtFDQLtPE |
| O60361 | Y136 | Sugiyama | NME2P1 | SLRFKPEELVDYKSCAHDWVyE___________________ |
| O60506 | Y373 | Sugiyama | SYNCRIP HNRPQ NSAP1 | ILEKAFsQFGKLERVKKLKDyAFIHFDERDGAVKAMEEMNG |
| O60568 | Y444 | Sugiyama | PLOD3 | LWSNFWGALSPDEYYARSEDyVELVQRKRVGVWNVPYISQA |
| O60664 | Y95 | Sugiyama | PLIN3 M6PRBP1 TIP47 | VsGAQPILSKLEPQIAsAsEyAHRGLDKLEENLPILQQPTE |
| O60716 | Y228 | Sugiyama | CTNND1 KIAA0384 | yPPDGysRHyEDGyPGGsDNyGsLsRVtRIEERyRPsMEGy |
| O60716 | Y280 | Sugiyama | CTNND1 KIAA0384 | QPQVRVGGssVDLHRFHPEPyGLEDDQRsMGyDDLDyGMMs |
| O60739 | Y30 | Sugiyama | EIF1B | FDPFADATKGDDLLPAGTEDyIHIRIQQRNGRKtLttVQGI |
| O60927 | T75 | Sugiyama | PPP1R11 HCGV TCTE5 | RRssKCCCIyEKPRAFGEsstEsDEEEEEGCGHtHCVRGHR |
| O60934 | Y679 | Sugiyama | NBN NBS NBS1 P95 | FRSLVIKNSTSRNPSGINDDyGQLKNFKKFKKVTYPGAGKL |
| O75116 | Y936 | Sugiyama | ROCK2 KIAA0619 | EITLTKADSEQLARsIAEEQysDLEKEKIMKELEIKEMMAR |
| O75208 | Y93 | Sugiyama | COQ9 C16orf49 HSPC326 PSEC0129 | PEssHsPPRYTDQGGEEEEDyEsEEQLQHRILTAALEFVPA |
| O75347 | Y75 | Sugiyama | TBCA | EILQEsRMMIPDCQRRLEAAyLDLQRILENEKDLEEAEEyK |
| O75369 | Y902 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | VQFNsPLPGDAVKDLDIIDNyDysHtVKYtPtQQGNMQVLV |
| O75369 | Y904 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | FNsPLPGDAVKDLDIIDNyDysHtVKYtPtQQGNMQVLVTY |
| O75508 | Y191 | PSP | CLDN11 OSP OTM | GGCVILCCAGDAQAFGENRFyyTAGsssPtHAKSAHV____ |
| O75508 | Y192 | PSP | CLDN11 OSP OTM | GCVILCCAGDAQAFGENRFyyTAGsssPtHAKSAHV_____ |
| O75718 | Y390 | Sugiyama | CRTAP CASP | ELyDFAKENIMDDDEGEVVEyVDDLLELEETS_________ |
| O75962 | Y2796 | GPS6|SIGNOR|iPTMNet|EPSD|PSP | TRIO | VLGPGMDGIMVTWKDNFDSFySEVAELGRGRFSVVKKCDQK |
| O94906 | Y105 | Sugiyama | PRPF6 C20orf14 | AGSLFSSGPYEKDDEEADAIyAALDKRMDERRKERREQREK |
| O95340 | Y182 | Sugiyama | PAPSS2 ATPSK2 | GLYKRARAGEIKGFTGIDsDyEKPEtPERVLKTNLSTVSDC |
| O95347 | Y938 | Sugiyama | SMC2 CAPE SMC2L1 PRO0324 | SKHKREAEDGAAKVSKMLKDyDWINAERHLFGQPNSAYDFK |
| P00338 | Y239 | Sugiyama | LDHA PIG19 | GtDKDKEQWKEVHKQVVEsAyEVIKLKGYtSWAIGLSVADL |
| P00491 | Y249 | Sugiyama | PNP NP | RHCGLRVFGFSLITNKVIMDyESLEKANHEEVLAAGKQAAQ |
| P00558 | Y161 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | KAEPAKIEAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNL |
| P04406 | Y314 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | tFDAGAGIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsK |
| P04406 | Y320 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsKE_____ |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P04818 | Y153 | Sugiyama | TYMS TS OK/SW-cl.29 | PVyGFQWRHFGAEyRDMEsDysGQGVDQLQRVIDTIKtNPD |
| P06733 | Y189 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | MILPVGAANFREAMRIGAEVyHNLKNVIKEKyGKDAtNVGD |
| P06733 | Y270 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EFFRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyPVV |
| P06733 | Y280 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | DFKsPDDPsRyIsPDQLADLyKsFIKDyPVVsIEDPFDQDD |
| P06733 | Y44 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | LFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKGVSK |
| P07205 | Y161 | Sugiyama | PGK2 PGKB | KAEPDKIEAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNL |
| P07205 | Y196 | Sugiyama | PGK2 PGKB | MVGVNLPHKASGFLMKKELDyFAKALENPVRPFLAILGGAK |
| P07237 | Y94 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | GSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFFRNGDTASPK |
| P07355 | Y188 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | RKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVKRKGT |
| P07355 | Y199 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | RAEDGsVIDyELIDQDARDLyDAGVKRKGTDVPKWIsIMTE |
| P07384 | Y42 | Sugiyama | CAPN1 CANPL1 PIG30 | RARELGLGRHENAIKyLGQDyEQLRVRCLQSGTLFRDEAFP |
| P07437 | Y50 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | IDPTGtyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEP |
| P07814 | Y827 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | EIGQNIssNssAsILESKsLyDEVAAQGEVVRKLKAEKSPK |
| P07900 | Y160 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | SAYLVAEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGEPM |
| P07900 | Y284 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEEEEKKDGDKKKKKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P07900 | Y309 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | ELNKtKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHF |
| P07900 | Y313 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | tKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P07900 | Y61 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KEIFLRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLI |
| P07949 | Y905 | SIGNOR|EPSD|PSP | RET CDHF12 CDHR16 PTC | GRKMKIsDFGLsRDVyEEDsyVKRsQGRIPVKWMAIESLFD |
| P08238 | Y155 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | SAYLVAEKVVVITKHNDDEQyAWEssAGGsFtVRADHGEPI |
| P08238 | Y276 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P08238 | Y301 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | ELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHF |
| P08238 | Y305 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | tKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P08238 | Y484 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVERVR |
| P08238 | Y485 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | EMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVERVRK |
| P08238 | Y56 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KEIFLRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDII |
| P08708 | Y84 | Sugiyama | RPS17 RPS17L | GPVRGISIKLQEEERERRDNyVPEVsALDQEIIEVDPDtKE |
| P09104 | Y44 | Sugiyama | ENO2 | LyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGKGVLK |
| P09234 | Y8 | Sugiyama | SNRPC | _____________MPKFyCDyCDtyLtHDsPsVRKTHCSGR |
| P0CG38 | Y1062 | Sugiyama | POTEI | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P0CG39 | Y1025 | Sugiyama | POTEJ | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P10809 | Y243 | Sugiyama | HSPD1 HSP60 | yIsPyFINtsKGQKCEFQDAyVLLsEKKIssIQsIVPALEI |
| P10809 | Y385 | Sugiyama | HSPD1 HSP60 | AQIEKRIQEIIEQLDVttsEyEKEKLNERLAKLsDGVAVLK |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11142 | Y431 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | TVLIKRNtTIPTKQtQtFttysDNQPGVLIQVyEGERAMTK |
| P11142 | Y443 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | KQtQtFttysDNQPGVLIQVyEGERAMTKDNNLLGKFELTG |
| P11142 | Y545 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | YKAEDEKQRDKVssKNsLEsyAFNMKATVEDEKLQGKINDE |
| P11274 | Y246 | Sugiyama | BCR BCR1 D22S11 | ASRPPYRGRssEssCGVDGDyEDAELNPRFLKDNLIDANGG |
| P12277 | Y125 | Sugiyama | CKB CKBB | EHKTDLNPDNLQGGDDLDPNyVLssRVRTGRSIRGFCLPPH |
| P12277 | Y39 | Sugiyama | CKB CKBB | EFPDLSAHNNHMAKVLtPELyAELRAKSTPSGFTLDDVIQT |
| P12814 | Y12 | GPS6|SIGNOR|ELM|EPSD|PSP | ACTN1 | _________MDHyDsQQTNDyMQPEEDWDRDLLLDPAWEKQ |
| P12814 | Y422 | Sugiyama | ACTN1 | KAsIHEAWtDGKEAMLRQKDyEtAtLsEIKALLKKHEAFEs |
| P13667 | Y448 | Sugiyama | PDIA4 ERP70 ERP72 | RAATQFWRSKVLEVAKDFPEytFAIADEEDyAGEVKDLGLs |
| P13667 | Y458 | Sugiyama | PDIA4 ERP70 ERP72 | VLEVAKDFPEytFAIADEEDyAGEVKDLGLsEsGEDVNAAI |
| P13929 | Y44 | Sugiyama | ENO3 | LHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGKGVLK |
| P14625 | Y258 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GNTLGRGTTITLVLKEEAsDyLELDTIKNLVKKYSQFINFP |
| P15259 | Y92 | Sugiyama | PGAM2 PGAMM | DGTDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEEQV |
| P15374 | Y141 | Sugiyama | UCHL3 | KFLEEsVsMsPEERARyLENyDAIRVtHEtsAHEGQTEAPs |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P17812 | Y473 | Sugiyama | CTPS1 CTPS | RRtLFQTKNsVMRKLyGDADyLEERHRHRFEVNPVWKKCLE |
| P17980 | Y381 | Sugiyama | PSMC3 TBP1 | ARARIMQIHSRKMNVsPDVNyEELARCTDDFNGAQCKAVCV |
| P17987 | Y545 | Sugiyama | TCP1 CCT1 CCTA | LRIDDLIKLHPESKDDKHGsyEDAVHsGALND_________ |
| P18669 | Y92 | Sugiyama | PGAM1 PGAMA CDABP0006 | DAIDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEAQV |
| P18858 | T183 | Sugiyama | LIG1 | sLTEAEVAtEKEGEDGDQPttPPKPLKTSKAEtPtEsVsEP |
| P19174 | Y771 | Sugiyama | PLCG1 PLC1 | KLRYPINEEALEKIGTAEPDyGALyEGRNPGFyVEANPMPT |
| P19174 | Y775 | Sugiyama | PLCG1 PLC1 | PINEEALEKIGTAEPDyGALyEGRNPGFyVEANPMPTFKCA |
| P19387 | Y142 | Sugiyama | POLR2C A-152E5.7 | SNsPRVIPVTSRNRDNDPNDyVEQDDILIVKLRKGQELRLR |
| P20042 | Y176 | Sugiyama | EIF2S2 EIF2B | GIsFsNQtGPAWAGSERDytyEELLNRVFNIMREKNPDMVA |
| P21980 | T368 | Sugiyama | TGM2 | QPGYEGWQALDPTPQEKsEGtyCCGPVPVRAIKEGDLstKy |
| P22234 | Y22 | Sugiyama | PAICS ADE2 AIRC PAIS | AtAEVLNIGKKLYEGKtKEVyELLDsPGKVLLQsKDQItAG |
| P22314 | S56 | Sugiyama | UBA1 A1S9T UBE1 | VPTNGMAKNGsEADIDEGLysRQLyVLGHEAMKRLQTSSVL |
| P22392 | Y151 | Sugiyama | NME2 NM23B | SLWFKPEELVDyKSCAHDWVyE___________________ |
| P23246 | Y488 | Sugiyama | SFPQ PSF | PMYQKEREtPPRFAQHGtFEyEysQRWKsLDEMEKQQREQV |
| P23246 | Y490 | Sugiyama | SFPQ PSF | YQKEREtPPRFAQHGtFEyEysQRWKsLDEMEKQQREQVEK |
| P23528 | T70 | Sugiyama | CFL1 CFL | EEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAtyE |
| P23528 | Y140 | Sugiyama | CFL1 CFL | SKDAIKKKLtGIKHELQANCyEEVKDRCTLAEKLGGsAVIs |
| P23528 | Y85 | Sugiyama | CFL1 CFL | DDPyAtFVKMLPDKDCRyALyDAtyEtKESKKEDLVFIFWA |
| P23528 | Y89 | Sugiyama | CFL1 CFL | AtFVKMLPDKDCRyALyDAtyEtKESKKEDLVFIFWAPESA |
| P23588 | Y609 | Sugiyama | EIF4B | sASKyAALsVDGEDENEGEDyAE__________________ |
| P24752 | Y214 | Sugiyama | ACAT1 ACAT MAT | GsCAENTAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNE |
| P25205 | Y19 | Sugiyama | MCM3 | __MAGtVVLDDVELREAQRDyLDFLDDEEDQGIyQsKVREL |
| P25398 | Y127 | Sugiyama | RPS12 | sCVVVKDYGKESQAKDVIEEyFKCKK_______________ |
| P26010 | Y753 | EPSD|PSP | ITGB7 | GGIVAVGLGLVLAYRLSVEIyDRREySRFEKEQQQLNWKQD |
| P26010 | Y758 | EPSD|PSP | ITGB7 | VGLGLVLAYRLSVEIyDRREySRFEKEQQQLNWKQDsNPLY |
| P26640 | Y601 | Sugiyama | VARS1 G7A VARS VARS2 | VDMDFGTGAVKITPAHDQNDyEVGQRHGLEAIsIMDsRGAL |
| P27348 | Y149 | Sugiyama | YWHAQ | LAEVACGDDRKQtIDNsQGAyQEAFDIsKKEMQPTHPIRLG |
| P27348 | Y48 | Sugiyama | YWHAQ | AVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSIEQK |
| P27695 | Y45 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | KSKTAAKKNDKEAAGEGPALyEDPPDQKtsPsGKPAtLKIC |
| P27797 | Y338 | Sugiyama | CALR CRTC | LWQVKSGTIFDNFLITNDEAyAEEFGNETWGVtKAAEKQMK |
| P29353 | Y427 | SIGNOR|Sugiyama | SHC1 SHC SHCA | RKQMPPPPPCPGRELFDDPsyVNVQNLDKARQAVGGAGPPN |
| P29401 | Y481 | Sugiyama | TKT | AANTKGICFIRTsRPENAIIyNNNEDFQVGQAKVVLKSKDD |
| P29692 | S162 | Sugiyama | EEF1D EF1D | AKKPAtPAEDDEDDDIDLFGsDNEEEDKEAAQLREERLRQY |
| P30086 | Y176 | Sugiyama | PEBP1 PBP PEBP | KKyELRAPVAGtCyQAEWDDyVPKLyEQLsGK_________ |
| P30101 | Y115 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | yGVsGyPtLKIFRDGEEAGAyDGPRtADGIVsHLKKQAGPA |
| P30101 | Y264 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | CPHMTEDNKDLIQGKDLLIAyyDVDyEKNAKGSNYWRNRVM |
| P30101 | Y265 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | PHMTEDNKDLIQGKDLLIAyyDVDyEKNAKGSNYWRNRVMM |
| P30101 | Y269 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | EDNKDLIQGKDLLIAyyDVDyEKNAKGSNYWRNRVMMVAKK |
| P30101 | Y67 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | LMLVEFFAPWCGHCKRLAPEyEAAAtRLKGIVPLAKVDCTA |
| P31153 | Y242 | Sugiyama | MAT2A AMS2 MATA2 | LKEKVIKAVVPAKyLDEDtIyHLQPsGRFVIGGPQGDAGLt |
| P31943 | Y266 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | yNGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGstFQst |
| P31946 | Y21 | Sugiyama | YWHAB | MTMDKsELVQKAKLAEQAERyDDMAAAMKAVtEQGHELsNE |
| P31946 | Y50 | Sugiyama | YWHAB | AVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSIEQK |
| P31947 | Y48 | Sugiyama | SFN HME1 | GAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsIEQK |
| P32119 | Y115 | Sugiyama | PRDX2 NKEFB TDPX1 | GLGPLNIPLLADVTRRLsEDyGVLKTDEGIAYRGLFIIDGK |
| P32121 | Y404 | Sugiyama | ARRB2 ARB2 ARR2 | DDIVFEDFARLRLKGMKDDDyDDQLC_______________ |
| P32969 | Y180 | Sugiyama | RPL9 OK/SW-cl.103; RPL9P7; RPL9P8; RPL9P9 | LIQQATTVKNKDIRKFLDGIyVsEKGtVQQADE________ |
| P33176 | Y516 | Sugiyama | KIF5B KNS KNS1 | EELAVNyDQKSQEVEDKTKEyELLSDELNQKsATLAsIDAE |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P34932 | S31 | Sugiyama | HSPA4 APG2 HSPH2 | QSCYVAVARAGGIETIANEysDRCtPACIsFGPKNRSIGAA |
| P35221 | S641 | Sugiyama | CTNNA1 | GIRDIRKAVLMIRtPEELDDsDFEtEDFDVRsRtsVQtEDD |
| P35222 | Y142 | SIGNOR|PSP | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | VQRLAEPSQMLKHAVVNLINyQDDAELATRAIPELTKLLND |
| P36871 | T426 | Sugiyama | PGM1 | KQsVEDILKDHWQKYGRNFFtRyDyEEVEAEGANKMMKDLE |
| P36871 | Y157 | Sugiyama | PGM1 | GPAPEAITDKIFQISKTIEEyAVCPDLKVDLGVLGKQQFDL |
| P36871 | Y428 | Sugiyama | PGM1 | sVEDILKDHWQKYGRNFFtRyDyEEVEAEGANKMMKDLEAL |
| P36871 | Y430 | Sugiyama | PGM1 | EDILKDHWQKYGRNFFtRyDyEEVEAEGANKMMKDLEALMF |
| P36871 | Y476 | Sugiyama | PGM1 | GKQFSANDKVYtVEKADNFEysDPVDGsIsRNQGLRLIFTD |
| P39019 | Y48 | Sugiyama | RPS19 | LKVPEWVDtVKLAKHKELAPyDENWFytRAAstARHLYLRG |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P41252 | Y148 | Sugiyama | IARS1 IARS | SAEWKSTVsRLGRWIDFDNDyKTLYPQFMESVWWVFKQLYD |
| P41567 | Y30 | Sugiyama | EIF1 SUI1 | FDPFADAsKGDDLLPAGTEDyIHIRIQQRNGRKtLttVQGI |
| P43243 | Y202 | Sugiyama | MATR3 KIAA0723 | RHFRRDsFDDRGPsLNPVLDyDHGsRsQEsGyyDRMDyEDD |
| P43243 | Y219 | Sugiyama | MATR3 KIAA0723 | VLDyDHGsRsQEsGyyDRMDyEDDRLRDGERCRDDsFFGEt |
| P47712 | Y456 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | DsDDEsHEPKGtENEDAGsDyQsDNQASWIHRMIMALVSDS |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P49023 | Y118 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP|Sugiyama | PXN | sNPQDsVGsPCsRVGEEEHVysFPNKQKsAEPsPtVMstsL |
| P49023 | Y31 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | PXN | LESTTSHISKRPVFLSEETPySYPTGNHTyQEIAVPPPVPP |
| P49327 | Y2034 | Sugiyama | FASN FAS | DYFVVFSSVSCGRGNAGQsNyGFANsAMERICEKRRHEGLP |
| P49327 | Y45 | Sugiyama | FASN FAS | NLIGGVDMVTDDDRRWKAGLyGLPRRsGKLKDLSRFDAsFF |
| P49736 | Y234 | Sugiyama | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | VFKERIsDMCKENREsLVVNyEDLAAREHVLAYFLPEAPAE |
| P49840 | Y279 | Sugiyama | GSK3A | LKLCDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTS |
| P49841 | Y216 | Sugiyama | GSK3B | LKLCDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTS |
| P50402 | Y94 | Sugiyama | EMD EDMD STA | yDLPKKEDALLyQsKGyNDDyyEEsyFTTRTyGEPEsAGPS |
| P50991 | Y269 | Sugiyama | CCT4 CCTD SRB | IQFCLSAPKTDMDNQIVVSDyAQMDRVLREERAYILNLVKQ |
| P51580 | Y13 | Sugiyama | TPMT | ________MDGTRTSLDIEEysDtEVQKNQVLTLEEWQDKW |
| P51813 | Y40 | iPTMNet|EPSD | BMX | KMSPNNYKERLFVLTKTNLSyyEyDKMKRGSRKGSIEIKKI |
| P52565 | Y156 | Sugiyama | ARHGDIA GDIA1 | GVKIDKtDyMVGsYGPRAEEyEFLtPVEEAPKGMLARGsYs |
| P54105 | Y214 | Sugiyama | CLNS1A CLCI ICLN | QsVssQYNMAGVRtEDsIRDyEDGMEVDttPtVAGQFEDAD |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P55072 | Y805 | Sugiyama | VCP HEL-220 HEL-S-70 | QGsGGGtGGsVYTEDNDDDLyG___________________ |
| P55795 | Y266 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | YGGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGssFQst |
| P56945 | Y165 | PSP | BCAR1 CAS CASS1 CRKAS | TSTFSKQTPHHPFPSPATDLyQVPPGPGGPAQDIyQVPPSA |
| P56945 | Y234 | Sugiyama | BCAR1 CAS CASS1 CRKAS | VPtRVGQGyVyEAAQPEQDEyDIPRHLLAPGPQDIyDVPPV |
| P56945 | Y410 | EPSD|PSP | BCAR1 CAS CASS1 CRKAS | PRERVLPPEVADGGVVDsGVyAVPPPAEREAPAEGKRLsAs |
| P56945 | Y664 | SIGNOR|iPTMNet|EPSD | BCAR1 CAS CASS1 CRKAS | tsQDsPDGQyENSEGGWMEDyDyVHLQGKEEFEKTQKELLE |
| P56945 | Y666 | SIGNOR|iPTMNet|EPSD | BCAR1 CAS CASS1 CRKAS | QDsPDGQyENSEGGWMEDyDyVHLQGKEEFEKTQKELLEKG |
| P60660 | Y86 | Sugiyama | MYL6 | DFEHFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVMG |
| P60660 | Y89 | Sugiyama | MYL6 | HFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVMGAEI |
| P60709 | T297 | Sugiyama | ACTB | TTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEI |
| P60709 | Y218 | Sugiyama | ACTB | ysFtttAEREIVRDIKEKLCyVALDFEQEMAtAAssssLEK |
| P60709 | Y240 | Sugiyama | ACTB | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P60709 | Y306 | Sugiyama | ACTB | DVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPstMK |
| P60709 | Y362 | Sugiyama | ACTB | GGsILAsLstFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P61158 | Y400 | Sugiyama | ACTR3 ARP3 | GGSMLASTPEFYQVCHTKKDyEEIGPsICRHNPVFGVMs__ |
| P61247 | Y256 | Sugiyama | RPS3A FTE1 MFTL | sssGKAtGDEtGAKVERADGyEPPVQEsV____________ |
| P61981 | Y20 | Sugiyama | YWHAG | _MVDREQLVQKARLAEQAERyDDMAAAMKNVtELNEPLsNE |
| P61981 | Y49 | Sugiyama | YWHAG | NVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSIEQK |
| P62191 | Y184 | Sugiyama | PSMC1 | MDDTDPLVTVMKVEKAPQETyADIGGLDNQIQEIKESVELP |
| P62191 | Y439 | Sugiyama | PSMC1 | FKKSKENVLyKKQEGtPEGLyL___________________ |
| P62258 | Y49 | Sugiyama | YWHAE | KVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssIEQK |
| P62269 | S96 | Sugiyama | RPS18 D6S218E | QYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLKK |
| P62269 | Y95 | Sugiyama | RPS18 D6S218E | RQYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLK |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62280 | Y55 | Sugiyama | RPS11 | RYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILsG |
| P62333 | Y328 | Sugiyama | PSMC6 SUG2 | ARLDILKIHAGPITKHGEIDyEAIVKLSDGFNGADLRNVCT |
| P62736 | Y242 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P62750 | Y144 | Sugiyama | RPL23A | VNtLIRPDGEKKAYVRLAPDyDALDVANKIGII________ |
| P62826 | Y146 | Sugiyama | RAN ARA24 OK/SW-cl.81 | IKDRKVKAKsIVFHRKKNLQyyDIsAKSNyNFEKPFLWLAR |
| P62906 | Y11 | Sugiyama | RPL10A NEDD6 | __________MSSKVsRDtLyEAVREVLHGNQRKRRKFLET |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P63000 | Y64 | EPSD|PSP | RAC1 TC25 MIG5 | VMVDGKPVNLGLWDTAGQEDyDRLRPLsYPQTDVFLICFSL |
| P63104 | Y19 | Sugiyama | YWHAZ | __MDKNELVQKAKLAEQAERyDDMAACMKsVtEQGAELsNE |
| P63104 | Y48 | Sugiyama | YWHAZ | sVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssIEQK |
| P63261 | T297 | Sugiyama | ACTG1 ACTG | TTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEI |
| P63261 | Y218 | Sugiyama | ACTG1 ACTG | ysFtttAEREIVRDIKEKLCyVALDFEQEMAtAAssssLEK |
| P63261 | Y240 | Sugiyama | ACTG1 ACTG | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P63261 | Y306 | Sugiyama | ACTG1 ACTG | DVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPstMK |
| P63261 | Y362 | Sugiyama | ACTG1 ACTG | GGsILAsLstFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P63267 | Y241 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68032 | Y242 | Sugiyama | ACTC1 ACTC | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68133 | Y242 | Sugiyama | ACTA1 ACTA | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68363 | Y432 | Sugiyama | TUBA1B | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| P68363 | Y451 | Sugiyama | TUBA1B | DyEEVGVDsVEGEGEEEGEEy____________________ |
| Q00169 | Y140 | Sugiyama | PITPNA PITPN | GTQENVHKLEPEAWKHVEAVyIDIADRSQVLSKDYKAEEDP |
| Q00839 | Y260 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | GDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVEEED |
| Q02809 | Y434 | Sugiyama | PLOD1 LLH PLOD | LWSNFWGALSADGYYARSEDyVDIVQGRRVGVWNVPYISNI |
| Q04446 | Y657 | Sugiyama | GBE1 | RVGTALPGKFKIVLDSDAAEyGGHQRLDHSTDFFSEAFEHN |
| Q04837 | Y73 | Sugiyama | SSBP1 SSBP | PVTIFSLATNEMWRsGDsEVyQLGDVsQKTTWHRISVFRPG |
| Q04917 | Y49 | Sugiyama | YWHAH YWHA1 | AVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSIEQK |
| Q05397 | S390 | iPTMNet|EPSD|Sugiyama | PTK2 FAK FAK1 | LPSIPKLANSEKQGMRtHAVsVsEtDDyAEIIDEEDtytMP |
| Q05397 | S392 | Sugiyama | PTK2 FAK FAK1 | SIPKLANSEKQGMRtHAVsVsEtDDyAEIIDEEDtytMPST |
| Q05397 | S677 | Sugiyama | PTK2 FAK FAK1 | KCWAYDPSRRPRFTELKAQLsTILEEEKAQQEERMRMEsRR |
| Q05397 | S850 | iPTMNet|EPSD | PTK2 FAK FAK1 | ERFLKPDVRLsRGsIDREDGsLQGPIGNQHIyQPVGKPDPA |
| Q05397 | S910 | Sugiyama | PTK2 FAK FAK1 | sLssPADsyNEGVKLQPQEIsPPPtANLDRSNDKVyENVTG |
| Q05397 | T394 | Sugiyama | PTK2 FAK FAK1 | PKLANSEKQGMRtHAVsVsEtDDyAEIIDEEDtytMPSTRD |
| Q05397 | Y397 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP|Sugiyama | PTK2 FAK FAK1 | ANSEKQGMRtHAVsVsEtDDyAEIIDEEDtytMPSTRDYEI |
| Q05397 | Y407 | SIGNOR|EPSD|PSP|Sugiyama | PTK2 FAK FAK1 | HAVsVsEtDDyAEIIDEEDtytMPSTRDYEIQRERIELGRC |
| Q05397 | Y570 | Sugiyama | PTK2 FAK FAK1 | RNVLVSSNDCVKLGDFGLsRyMEDstyyKAsKGKLPIKWMA |
| Q05397 | Y576 | GPS6|SIGNOR|ELM|EPSD|PSP | PTK2 FAK FAK1 | SNDCVKLGDFGLsRyMEDstyyKAsKGKLPIKWMAPESINF |
| Q05397 | Y577 | GPS6|SIGNOR|ELM|EPSD|PSP | PTK2 FAK FAK1 | NDCVKLGDFGLsRyMEDstyyKAsKGKLPIKWMAPESINFR |
| Q05397 | Y861 | SIGNOR | PTK2 FAK FAK1 | RGsIDREDGsLQGPIGNQHIyQPVGKPDPAAPPKKPPRPGA |
| Q05397 | Y925 | iPTMNet|EPSD|Sugiyama | PTK2 FAK FAK1 | QPQEIsPPPtANLDRSNDKVyENVTGLVKAVIEMSSKIQPA |
| Q06830 | Y116 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | GLGPMNIPLVSDPKRtIAQDyGVLKADEGIsFRGLFIIDDK |
| Q07666 | Y145 | Sugiyama | KHDRBS1 SAM68 | LtAEIEKIQKGDSKKDDEENyLDLFsHKNMKLKERVLIPVK |
| Q12874 | T475 | Sugiyama | SF3A3 SAP61 | AVSLWAKLKLQKASERWQPDtEEEyEDssGNVVNKKTYEDL |
| Q12874 | Y479 | Sugiyama | SF3A3 SAP61 | WAKLKLQKASERWQPDtEEEyEDssGNVVNKKTYEDLKRQG |
| Q13098 | S468 | Sugiyama | GPS1 COPS1 CSN1 | RRAKAMMLRAAVLRNQIHVKsPPREGsQGELtPANsQsRMs |
| Q13263 | Y133 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | TVVDCPVCKQQCFSKDIVENyFMRDsGsKAATDAQDANQCC |
| Q13263 | Y242 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | ESCDTLTCRDCQLNAHKDHQyQFLEDAVRNQRKLLAsLVKR |
| Q13442 | Y70 | Sugiyama | PDAP1 HASPP28 | DPKKEKKsLDsDEsEDEEDDyQQKRKGVEGLIDIENPNRVA |
| Q13561 | S83 | Sugiyama | DCTN2 DCTN50 | GTKGLDFsDRIGKTKRtGyEsGEyEMLGEGLGVKETPQQKY |
| Q13561 | Y6 | Sugiyama | DCTN2 DCTN50 | _______________MADPKyADLPGIARNEPDVYETSDLP |
| Q13561 | Y86 | Sugiyama | DCTN2 DCTN50 | GLDFsDRIGKTKRtGyEsGEyEMLGEGLGVKETPQQKYQRL |
| Q13765 | T119 | Sugiyama | NACA HSD48 | SKNILFVITKPDVYKSPAsDtyIVFGEAKIEDLsQQAQLAA |
| Q13765 | Y120 | Sugiyama | NACA HSD48 | KNILFVITKPDVYKSPAsDtyIVFGEAKIEDLsQQAQLAAA |
| Q14155 | S518 | Sugiyama | ARHGEF7 COOL1 KIAA0142 P85SPR PAK3BP PIXB Nbla10314 | ERYLLLFPNVLLMLSASPRMsGFIyQGKLPtTGMTITKLED |
| Q14161 | S590 | Sugiyama | GIT2 KIAA0148 | sRDEsARRASRLEKQNstPEsDYDNTPNDMEPDGMGSSRKG |
| Q14257 | Y311 | Sugiyama | RCN2 ERC55 | NPDLFLtsEAtDyGRQLHDDyFyHDEL______________ |
| Q14257 | Y313 | Sugiyama | RCN2 ERC55 | DLFLtsEAtDyGRQLHDDyFyHDEL________________ |
| Q14451 | Y188 | GPS6|EPSD|PSP | GRB7 | QAAWPVGGDSRFVFRKNFAKyELFKssPHSLFPEKMVSSCL |
| Q14451 | Y338 | GPS6|EPSD|PSP | GRB7 | FCSEDEQSRTCWLAAFRLFKyGVQLYKNYQQAQSRHLHPsC |
| Q14457 | Y233 | EPSD|PSP | BECN1 GT197 | EKVQAEAERLDQEEAQyQREysEFKRQQLELDDELKSVENQ |
| Q14568 | Y160 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | SAYLVAEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGERM |
| Q14568 | Y283 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | sDEEEEKKDGDKKKKKTKEKyIDQEELNKTKPIWTRNPDDI |
| Q15052 | S488 | Sugiyama | ARHGEF6 COOL2 KIAA0006 PIXA | ERYLMLFSNVLIMLSASPRMsGFIYQGKIPIAGTVVTRLDE |
| Q15054 | Y119 | Sugiyama | POLD3 KIAA0039 | HVYSIQKAMLKDSGPLFNTDyDILKSNLQNCSKFSAIQCAA |
| Q15149 | Y3362 | Sugiyama | PLEC PLEC1 | TGLsLLPLSEKAARARQEELySELQAREtFEKTPVEVPVGG |
| Q15181 | Y169 | Sugiyama | PPA1 IOPPP PP | EGETDWKVIAINVDDPDAANyNDINDVKRLKPGYLEATVDW |
| Q15293 | Y278 | Sugiyama | RCN1 RCN | LNKDGKLDKDEIRHWILPQDyDHAQAEARHLVyESDKNKDE |
| Q15369 | Y18 | Sugiyama | ELOC TCEB1 | ___MDGEEKtyGGCEGPDAMyVKLISSDGHEFIVKREHALt |
| Q15369 | Y8 | Sugiyama | ELOC TCEB1 | _____________MDGEEKtyGGCEGPDAMyVKLISSDGHE |
| Q15459 | Y456 | Sugiyama | SF3A1 SAP114 | PRWLEQRDRSIREKQsDDEVyAPGLDIESsLKQLAERRtDI |
| Q15650 | T280 | Sugiyama | TRIP4 RQT4 | EKAIKHKDKLLEFDRtsIRRtQVIDDESDyFASDSNQWLSK |
| Q562R1 | Y241 | Sugiyama | ACTBL2 | ALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPEA |
| Q58FF6 | Y32 | Sugiyama | HSP90AB4P | KEIFLQELISNASDALDKIRyEsLtDPsKLDGGKELKIDII |
| Q58FF7 | Y56 | Sugiyama | HSP90AB3P HSP90BC | EEIFLQELISNASDALDKIRyEsLtDPsKLDsGKELKIDII |
| Q58FF8 | Y198 | Sugiyama | HSP90AB2P HSP90BB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKTKPIWTRNTEDI |
| Q58FF8 | Y260 | Sugiyama | HSP90AB2P HSP90BB | VRYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQVW |
| Q58FF8 | Y261 | Sugiyama | HSP90AB2P HSP90BB | RYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQVWK |
| Q58FF8 | Y56 | Sugiyama | HSP90AB2P HSP90BB | KEIFLWELISNASDALDKIRyEsLtDPsKLDsGKELKIDII |
| Q5JTH9 | Y1251 | Sugiyama | RRP12 KIAA0690 | AEYKAKKAKGDVKKKGRPDPyAyIPLNRSKLNRRKKMKLQG |
| Q5T035 | Y67 | Sugiyama | FAM120A2P C9orf129 | SEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyERSLPIN |
| Q5VV41 | Y216 | Sugiyama | ARHGEF16 EPHEXIN4 NBR | KKTLGRKRGHKGsFKDDPQLyQEIQERGLNtsQEsDDDILD |
| Q5XKE5 | Y341 | Sugiyama | KRT79 K6L KB38 KRT6L | QYELIAQRSRAEAEAWYQTKyEELQVTAGKHGDNLRDTKNE |
| Q6PCE3 | S175 | Sugiyama | PGM2L1 BM32A | PFVPYAVQKLKAVAGVMItAsHNRKEDNGYKVYWETGAQIT |
| Q6PFW1 | Y267 | Sugiyama | PPIP5K1 HISPPD2A IP6K IPS1 KIAA0377 VIP1 | YEEFMPTDGTDVKVytVGPDyAHAEARKSPALDGKVERDSE |
| Q6PKG0 | Y633 | Sugiyama | LARP1 KIAA0731 LARP | MEQMDGRKNtFtAWsDEEsDyEIDDRDVNKILIVtQtPHyM |
| Q6S8J3 | Y1062 | Sugiyama | POTEE A26C1A POTE2 | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| Q6S8J3 | Y918 | Sugiyama | POTEE A26C1A POTE2 | YRFTTMAEREIVRDIKEKLCyVALDFEQEMAtAAssssLEK |
| Q6S8J3 | Y940 | Sugiyama | POTEE A26C1A POTE2 | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| Q71U36 | Y432 | Sugiyama | TUBA1A TUBA3 | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| Q71U36 | Y451 | Sugiyama | TUBA1A TUBA3 | DyEEVGVDsVEGEGEEEGEEy____________________ |
| Q7KZF4 | Y476 | Sugiyama | SND1 TDRD11 | SKGLATVIRYRQDDDQRssHyDELLAAEARAIKNGKGLHSK |
| Q86UK7 | Y306 | Sugiyama | ZNF598 | QFSYAPRHSRRNEGVVGGEDyEEVDRysRQGRVARAGTRGA |
| Q8N0Y7 | Y92 | Sugiyama | PGAM4 PGAM3 | DAIDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEAQV |
| Q8NEY8 | Y58 | Sugiyama | PPHLN1 HSPC206 HSPC232 | PPLLDRPGEGsYNRYYSHVDyRDYDEGRSFSHDRRSGPPHR |
| Q8NFD5 | S1744 | Sugiyama | ARID1B BAF250B DAN15 KIAA1235 OSA2 | ALDTINILLYDDSTVATFNLsQLSGFLELLVEYFRKCLIDI |
| Q8NI22 | Y138 | Sugiyama | MCFD2 SDNSF | INIIDGVLRDDDKNNDGyIDyAEFAKSLQ____________ |
| Q8WVV9 | Y34 | Sugiyama | HNRNPLL HNRPLL SRRF BLOCK24 | EDREYESQAKRLKTEEGEIDysAEEGENRREAtPRGGGDGG |
| Q92882 | Y207 | Sugiyama | OSTF1 | sLLKKKQGTDAVRtLsNAEDyLDDEDsD_____________ |
| Q96AE4 | Y58 | Sugiyama | FUBP1 | ARQIAAKIGGDAGtsLNsNDyGyGGQKRPLEDGDQPDAKKV |
| Q96G46 | T273 | Sugiyama | DUS3L | GAPRQENCGAQQVPAGPGtstPPssPVRtCGPLtDEDVVRL |
| Q96P70 | Y889 | Sugiyama | IPO9 IMP9 KIAA1192 RANBP9 HSPC273 | HGINADDKRLQDIRVKGEEIysMDEGIRTRSKSAKNPERWT |
| Q96QK1 | Y791 | Sugiyama | VPS35 MEM3 TCCCTA00141 | HNtLEHLRLRREsPEsEGPIyEGLIL_______________ |
| Q99426 | Y98 | Sugiyama | TBCB CG22 CKAP1 | PVDDGCRIHVIDHsGARLGEyEDVSRVEKytIsQEAyDQRQ |
| Q99459 | Y459 | Sugiyama | CDC5L KIAA0432 PCDC5RP | PGRtPLRDKLNINPEDGMADysDPsyVKQMERESREHLRLG |
| Q99848 | Y265 | Sugiyama | EBNA1BP2 EBP2 | NQKFGFGGKKKGSKWNtREsyDDVssFRAKTAHGRGLKRPG |
| Q99961 | Y315 | GPS6|SIGNOR|ELM|EPSD|PSP | SH3GL1 CNSA1 SH3D2B | PIRtPSRSMPPLDQPSCKALyDFEPENDGELGFHEGDVITL |
| Q9BQE3 | Y432 | Sugiyama | TUBA1C TUBA6 | GMEEGEFSEAREDMAALEKDyEEVGADsADGEDEGEEy___ |
| Q9BQE3 | Y449 | Sugiyama | TUBA1C TUBA6 | EKDyEEVGADsADGEDEGEEy____________________ |
| Q9BRS2 | T509 | Sugiyama | RIOK1 RIO1 | QVEERtCsDsEDIGssECsDtDSEEQGDHARPKKHTTDPDI |
| Q9BUP3 | Y62 | Sugiyama | HTATIP2 CC3 TIP30 | GLFSKVTLIGRRKLTFDEEAyKNVNQEVVDFEKLDDYASAF |
| Q9BYX7 | Y240 | Sugiyama | POTEKP ACTBL3 FKSG30 | ALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPEA |
| Q9BYX7 | Y362 | Sugiyama | POTEKP ACTBL3 FKSG30 | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| Q9H1E3 | Y146 | Sugiyama | NUCKS1 NUCKS JC7 | QEKDsGsDEDFLMEDDDDsDyGSsKKKNKKMVKKSKPERKE |
| Q9H1E3 | Y26 | Sugiyama | NUCKS1 NUCKS JC7 | RNRKVVDysQFQEsDDADEDyGRDsGPPtKKIRSsPREAKN |
| Q9H4F8 | Y407 | Sugiyama | SMOC1 | FKRYVKKKAKPKKCARRFtDyCDLNKDKVISLPELKGCLGV |
| Q9H5V8 | Y734 | EPSD|PSP | CDCP1 TRASK UNQ2486/PRO5773 | EMPRQPKKFQKGRKDNDSHVyAVIEDTMVyGHLLQDSSGSF |
| Q9H6T3 | Y90 | Sugiyama | RPAP3 | KESSKKTREENTKNRIKsyDyEAWAKLDVDRILDELDKDDs |
| Q9H9S0 | Y174 | SIGNOR|EPSD|PSP | NANOG | QKNNWPKNSNGVTQKASAPTyPSLYSSYHQGCLVNPTGNLP |
| Q9H9S0 | Y35 | SIGNOR|EPSD|PSP | NANOG | EASDCKESSPMPVICGPEENyPSLQMSSAEMPHTETVsPLP |
| Q9NPI1 | Y190 | Sugiyama | BRD7 BP75 CELTIX1 | MIIKHPMDFSTMKEKIKNNDyQsIEELKDNFKLMCTNAMIY |
| Q9NRX4 | Y116 | Sugiyama | PHPT1 PHP14 CGI-202 HSPC141 | AyGPAQHAISTEKIKAKyPDyEVtWANDGy___________ |
| Q9NUL3 | Y326 | Sugiyama | STAU2 | MNPISRLAQIQQAKKEKEPDyVLLSERGMPRRREFVMQVKV |
| Q9NVS9 | Y256 | Sugiyama | PNPO | LPtGDsPLGPMTHRGEEDWLyERLAP_______________ |
| Q9NYU2 | Y449 | Sugiyama | UGGT1 GT UGCGL1 UGGT UGT1 UGTR | IEGLSLHNVLKLNIQPsEADyAVDIRSPAISWVNNLEVDSR |
| Q9NZB2 | Y418 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | SEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyERssPIN |
| Q9UBR2 | Y76 | Sugiyama | CTSZ | YLSPADLPKSWDWRNVDGVNyAsItRNQHIPQYCGSCWAHA |
| Q9UK59 | Y533 | Sugiyama | DBR1 | LsDEHEPEQRKKIKRRNQAIyAAVDDDDDDAA_________ |
| Q9UKV3 | S388 | Sugiyama | ACIN1 ACINUS KIAA0670 | EEEEREIKssQGLKEKsKsPsPPRLtEDRKKAsLVALPEQt |
| Q9UKV3 | Y1086 | Sugiyama | ACIN1 ACINUS KIAA0670 | RTALHGVKWPQSNPKFLCADyAEQDELDyHRGLLVDRPsEt |
| Q9UPR0 | T584 | Sugiyama | PLCL2 KIAA1092 PLCE2 | KILIKAKKLsSNCSGVEGDVtDEDEGAEMSQRMGKENMEQP |
| Q9UQL6 | Y642 | PSP | HDAC5 KIAA0600 | PGAGYKKLFSDAQPLQPLQVyQAPLSLATVPHQALGRTQss |
| Q9Y281 | Y85 | Sugiyama | CFL2 | EDPYtsFVKLLPLNDCRyALyDAtyEtKESKKEDLVFIFWA |
| Q9Y281 | Y89 | Sugiyama | CFL2 | tsFVKLLPLNDCRyALyDAtyEtKESKKEDLVFIFWAPESA |
| Q9Y2X7 | Y321 | EPSD|PSP | GIT1 | NHSTLVTERSAVPFLPVNPEySATRNQGRQKLARFNAREFA |
| Q9Y450 | Y58 | Sugiyama | HBS1L HBS1 KIAA1038 | AQFIYSRRDKPsVEPVEEyDyEDLKEssNsVsNHQLSGFDQ |
| Q9Y490 | Y1893 | Sugiyama | TLN1 KIAA1027 TLN | TKsNtsPEELGPLANQLTsDyGRLAsEAKPAAVAAENEEIG |
| Q9Y4H2 | Y632 | Sugiyama | IRS2 | LCPsCPAssPKVAyHPyPEDyGDIEIGsHRssssNLGADDG |
| Q9Y4L1 | Y759 | Sugiyama | HYOU1 GRP170 HSPH4 ORP150 | AANsLEAFIFEtQDKLyQPEyQEVsTEEQREEISGKLSAAS |
| Q9Y5S9 | S56 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWILF |
| Q9Y5S9 | Y96 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | FVTGVHEEATEEDIHDKFAEyGEIKNIHLNLDRRTGYLKGy |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.801696e-08 | 7.744 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 9.769851e-08 | 7.010 | 1 | 1 |
| Apoptotic execution phase | R-HSA-75153 | 1.008320e-06 | 5.996 | 1 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 4.292937e-06 | 5.367 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 6.763680e-06 | 5.170 | 1 | 0 |
| Developmental Biology | R-HSA-1266738 | 2.861000e-05 | 4.543 | 1 | 0 |
| Ephrin signaling | R-HSA-3928664 | 7.515287e-05 | 4.124 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.423688e-04 | 3.847 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.498398e-04 | 3.824 | 1 | 1 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 1.939123e-04 | 3.712 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.130781e-04 | 3.671 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 3.072515e-04 | 3.513 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 3.692155e-04 | 3.433 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 6.907562e-04 | 3.161 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.256923e-03 | 2.901 | 1 | 1 |
| Signaling by Hippo | R-HSA-2028269 | 1.256923e-03 | 2.901 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.725157e-03 | 2.763 | 1 | 0 |
| Signal Transduction | R-HSA-162582 | 1.835262e-03 | 2.736 | 1 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 2.119843e-03 | 2.674 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 2.493714e-03 | 2.603 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 3.931236e-03 | 2.405 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 4.160122e-03 | 2.381 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 4.878524e-03 | 2.312 | 1 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 5.809107e-03 | 2.236 | 1 | 0 |
| Integrin signaling | R-HSA-354192 | 6.232526e-03 | 2.205 | 1 | 1 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 5.917228e-03 | 2.228 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 6.306952e-03 | 2.200 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 7.626651e-03 | 2.118 | 1 | 1 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 9.076698e-03 | 2.042 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 1.032998e-02 | 1.986 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.231566e-02 | 1.910 | 1 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.283211e-02 | 1.892 | 1 | 1 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.421020e-02 | 1.847 | 1 | 1 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.421020e-02 | 1.847 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.422140e-02 | 1.847 | 1 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.564930e-02 | 1.806 | 1 | 1 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 1.714816e-02 | 1.766 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.901033e-02 | 1.721 | 1 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.977949e-02 | 1.704 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 2.032024e-02 | 1.692 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.032024e-02 | 1.692 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 2.098998e-02 | 1.678 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 2.371676e-02 | 1.625 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 2.768114e-02 | 1.558 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 3.027725e-02 | 1.519 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 3.027725e-02 | 1.519 | 0 | 0 |
| BDNF activates NTRK2 (TRKB) signaling | R-HSA-9024909 | 3.705755e-02 | 1.431 | 0 | 0 |
| NTF3 activates NTRK2 (TRKB) signaling | R-HSA-9025046 | 3.705755e-02 | 1.431 | 0 | 0 |
| NTF4 activates NTRK2 (TRKB) signaling | R-HSA-9026357 | 3.705755e-02 | 1.431 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 5.507145e-02 | 1.259 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 5.507145e-02 | 1.259 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 6.395246e-02 | 1.194 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 6.395246e-02 | 1.194 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 6.395246e-02 | 1.194 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 7.275054e-02 | 1.138 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 7.275054e-02 | 1.138 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 7.275054e-02 | 1.138 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 8.146646e-02 | 1.089 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 8.146646e-02 | 1.089 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 9.010100e-02 | 1.045 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 9.865489e-02 | 1.006 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 9.865489e-02 | 1.006 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 9.865489e-02 | 1.006 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 9.865489e-02 | 1.006 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.071289e-01 | 0.970 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.155237e-01 | 0.937 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 1.320789e-01 | 0.879 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 1.402407e-01 | 0.853 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 1.402407e-01 | 0.853 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 1.402407e-01 | 0.853 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 1.483263e-01 | 0.829 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.483263e-01 | 0.829 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 1.563362e-01 | 0.806 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.642714e-01 | 0.784 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.642714e-01 | 0.784 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 5.302129e-02 | 1.276 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 1.721324e-01 | 0.764 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 1.721324e-01 | 0.764 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 5.789713e-02 | 1.237 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 1.799199e-01 | 0.745 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 1.799199e-01 | 0.745 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 1.876347e-01 | 0.727 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 1.876347e-01 | 0.727 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.028486e-01 | 0.693 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 8.158120e-02 | 1.088 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.103490e-01 | 0.677 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 2.177794e-01 | 0.662 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 4.204129e-02 | 1.376 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 9.291268e-02 | 1.032 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 2.251403e-01 | 0.648 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 2.324323e-01 | 0.634 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 2.396562e-01 | 0.620 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 2.396562e-01 | 0.620 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 2.396562e-01 | 0.620 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 5.430800e-02 | 1.265 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.106904e-01 | 0.956 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 2.468126e-01 | 0.608 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.137351e-01 | 0.944 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 2.609251e-01 | 0.583 | 1 | 1 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 2.678826e-01 | 0.572 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.678826e-01 | 0.572 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.678826e-01 | 0.572 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 2.747750e-01 | 0.561 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 2.747750e-01 | 0.561 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 2.747750e-01 | 0.561 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 2.747750e-01 | 0.561 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 2.816029e-01 | 0.550 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 2.883669e-01 | 0.540 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 8.506319e-02 | 1.070 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 2.950677e-01 | 0.530 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 2.950677e-01 | 0.530 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.649485e-01 | 0.783 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 3.082818e-01 | 0.511 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 3.082818e-01 | 0.511 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 3.723897e-02 | 1.429 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 2.816029e-01 | 0.550 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 9.010100e-02 | 1.045 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.103490e-01 | 0.677 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 2.158423e-01 | 0.666 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 5.507145e-02 | 1.259 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 9.865489e-02 | 1.006 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 3.936354e-02 | 1.405 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 1.483263e-01 | 0.829 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 2.678826e-01 | 0.572 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.103490e-01 | 0.677 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 2.883669e-01 | 0.540 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 2.992462e-01 | 0.524 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 2.992462e-01 | 0.524 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.749630e-01 | 0.757 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 6.808883e-02 | 1.167 | 1 | 0 |
| Myogenesis | R-HSA-525793 | 2.609251e-01 | 0.583 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.716136e-01 | 0.765 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 1.563362e-01 | 0.806 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 1.884608e-01 | 0.725 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 3.114586e-02 | 1.507 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 2.883669e-01 | 0.540 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 5.507145e-02 | 1.259 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 5.507145e-02 | 1.259 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 9.010100e-02 | 1.045 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.155237e-01 | 0.937 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 1.155237e-01 | 0.937 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 1.320789e-01 | 0.879 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.402407e-01 | 0.853 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.642714e-01 | 0.784 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 1.952774e-01 | 0.709 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 2.028486e-01 | 0.693 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.388129e-01 | 0.858 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 2.574789e-01 | 0.589 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 2.888215e-01 | 0.539 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 3.027161e-01 | 0.519 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.952774e-01 | 0.709 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 2.816029e-01 | 0.550 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.468126e-01 | 0.608 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 2.251403e-01 | 0.648 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 5.283687e-02 | 1.277 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.883669e-01 | 0.540 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.716136e-01 | 0.765 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 1.071289e-01 | 0.970 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.155237e-01 | 0.937 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 3.516046e-02 | 1.454 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 3.516046e-02 | 1.454 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 1.563362e-01 | 0.806 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.563362e-01 | 0.806 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.642714e-01 | 0.784 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 3.017058e-01 | 0.520 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.749630e-01 | 0.757 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 2.173018e-01 | 0.663 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 3.017058e-01 | 0.520 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 7.339052e-02 | 1.134 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 7.339052e-02 | 1.134 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 2.246797e-01 | 0.648 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.071289e-01 | 0.970 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 2.177794e-01 | 0.662 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 2.020968e-01 | 0.694 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 2.816029e-01 | 0.550 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 1.320506e-01 | 0.879 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.261225e-01 | 0.899 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 1.320506e-01 | 0.879 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 1.384620e-01 | 0.859 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 1.384620e-01 | 0.859 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 8.719091e-02 | 1.060 | 1 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 1.876347e-01 | 0.727 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 2.678826e-01 | 0.572 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 7.275054e-02 | 1.138 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 9.865489e-02 | 1.006 | 0 | 0 |
| Endosomal/Vacuolar pathway | R-HSA-1236977 | 1.320789e-01 | 0.879 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.402407e-01 | 0.853 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.642714e-01 | 0.784 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 7.072324e-02 | 1.150 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.468126e-01 | 0.608 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 2.468126e-01 | 0.608 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 2.747750e-01 | 0.561 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.388129e-01 | 0.858 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.950677e-01 | 0.530 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 3.252113e-02 | 1.488 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 1.850723e-01 | 0.733 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 2.075482e-01 | 0.683 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 9.581367e-02 | 1.019 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.236721e-01 | 0.908 | 1 | 1 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.883669e-01 | 0.540 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 2.816029e-01 | 0.550 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 3.082818e-01 | 0.511 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 6.444012e-02 | 1.191 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.471720e-01 | 0.832 | 1 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.783305e-01 | 0.749 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 7.275054e-02 | 1.138 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 7.275054e-02 | 1.138 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 9.010100e-02 | 1.045 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 1.238402e-01 | 0.907 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 2.251403e-01 | 0.648 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 2.609251e-01 | 0.583 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 2.678826e-01 | 0.572 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 2.883669e-01 | 0.540 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 2.853426e-01 | 0.545 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.082818e-01 | 0.511 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 1.515930e-01 | 0.819 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 6.292204e-02 | 1.201 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 2.816029e-01 | 0.550 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 2.678826e-01 | 0.572 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.692179e-01 | 0.772 | 1 | 1 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 6.121012e-02 | 1.213 | 1 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.642714e-01 | 0.784 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.952774e-01 | 0.709 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.028486e-01 | 0.693 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 2.950677e-01 | 0.530 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.766261e-01 | 0.753 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.801570e-01 | 0.744 | 1 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 2.679301e-01 | 0.572 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.483263e-01 | 0.829 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.642714e-01 | 0.784 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 2.853426e-01 | 0.545 | 1 | 1 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 1.485059e-01 | 0.828 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 9.752148e-02 | 1.011 | 1 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 1.563362e-01 | 0.806 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.028486e-01 | 0.693 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.251403e-01 | 0.648 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 2.950677e-01 | 0.530 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 1.673898e-01 | 0.776 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.202669e-01 | 0.920 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 2.020968e-01 | 0.694 | 1 | 0 |
| Influenza Infection | R-HSA-168255 | 2.876868e-01 | 0.541 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.469693e-01 | 0.833 | 1 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 6.395246e-02 | 1.194 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 2.539020e-01 | 0.595 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 2.609251e-01 | 0.583 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.020968e-01 | 0.694 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.723775e-01 | 0.565 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 2.028486e-01 | 0.693 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 2.177794e-01 | 0.662 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 9.602917e-02 | 1.018 | 1 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 2.672943e-01 | 0.573 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 2.748975e-01 | 0.561 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 3.027161e-01 | 0.519 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 2.088103e-01 | 0.680 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 2.748975e-01 | 0.561 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 2.748975e-01 | 0.561 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 1.238402e-01 | 0.907 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.402407e-01 | 0.853 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.642714e-01 | 0.784 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.799199e-01 | 0.745 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 2.028486e-01 | 0.693 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 3.082818e-01 | 0.511 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 2.992462e-01 | 0.524 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 2.747750e-01 | 0.561 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.331379e-01 | 0.632 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 2.666371e-01 | 0.574 | 1 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.721324e-01 | 0.764 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 2.079637e-01 | 0.682 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.175219e-01 | 0.930 | 1 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 4.600333e-02 | 1.337 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 1.952774e-01 | 0.709 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 1.952774e-01 | 0.709 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 2.123971e-01 | 0.673 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 2.955731e-01 | 0.529 | 1 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.396562e-01 | 0.620 | 1 | 1 |
| Neurotransmitter release cycle | R-HSA-112310 | 2.400815e-01 | 0.620 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 2.901026e-01 | 0.537 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 2.324323e-01 | 0.634 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.324323e-01 | 0.634 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 1.195589e-01 | 0.922 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 2.099166e-01 | 0.678 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 1.106904e-01 | 0.956 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 2.539020e-01 | 0.595 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 2.539020e-01 | 0.595 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 4.830194e-02 | 1.316 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 1.721324e-01 | 0.764 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 1.721324e-01 | 0.764 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 2.747750e-01 | 0.561 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.017185e-01 | 0.993 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 2.783803e-01 | 0.555 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 1.816928e-01 | 0.741 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 6.808883e-02 | 1.167 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 2.702192e-01 | 0.568 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 1.198884e-01 | 0.921 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.124125e-01 | 0.673 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 1.401767e-01 | 0.853 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.651437e-02 | 1.015 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 1.583316e-01 | 0.800 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 1.789573e-01 | 0.747 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 8.652330e-02 | 1.063 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.017058e-01 | 0.520 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.222148e-01 | 0.653 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 1.420282e-01 | 0.848 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 9.874041e-02 | 1.006 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.517671e-01 | 0.819 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 2.774713e-01 | 0.557 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.884608e-01 | 0.725 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.296707e-01 | 0.639 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 3.096470e-01 | 0.509 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.096470e-01 | 0.509 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.096470e-01 | 0.509 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 3.131075e-01 | 0.504 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 3.131075e-01 | 0.504 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 3.147963e-01 | 0.502 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 3.147963e-01 | 0.502 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 3.147963e-01 | 0.502 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.147963e-01 | 0.502 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 3.147963e-01 | 0.502 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 3.147963e-01 | 0.502 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 3.165644e-01 | 0.500 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 3.184808e-01 | 0.497 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 3.200173e-01 | 0.495 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 3.200173e-01 | 0.495 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 3.212498e-01 | 0.493 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 3.212498e-01 | 0.493 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 3.212498e-01 | 0.493 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 3.212498e-01 | 0.493 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 3.212498e-01 | 0.493 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 3.212498e-01 | 0.493 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 3.276430e-01 | 0.485 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.276430e-01 | 0.485 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 3.303507e-01 | 0.481 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 3.339763e-01 | 0.476 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 3.339763e-01 | 0.476 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 3.339763e-01 | 0.476 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 3.339763e-01 | 0.476 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 3.339763e-01 | 0.476 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 3.339763e-01 | 0.476 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 3.339763e-01 | 0.476 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 3.339763e-01 | 0.476 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 3.402503e-01 | 0.468 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 3.402503e-01 | 0.468 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 3.402503e-01 | 0.468 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 3.406412e-01 | 0.468 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 3.464657e-01 | 0.460 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 3.464657e-01 | 0.460 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 3.467331e-01 | 0.460 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 3.474749e-01 | 0.459 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 3.493317e-01 | 0.457 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 3.526228e-01 | 0.453 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 3.526228e-01 | 0.453 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 3.526228e-01 | 0.453 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 3.526228e-01 | 0.453 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 3.526228e-01 | 0.453 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 3.526228e-01 | 0.453 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 3.542855e-01 | 0.451 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 3.576816e-01 | 0.447 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 3.587223e-01 | 0.445 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 3.587223e-01 | 0.445 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 3.587223e-01 | 0.445 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 3.587223e-01 | 0.445 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 3.587223e-01 | 0.445 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 3.587223e-01 | 0.445 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.587223e-01 | 0.445 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 3.587223e-01 | 0.445 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 3.587223e-01 | 0.445 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 3.587223e-01 | 0.445 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 3.610713e-01 | 0.442 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 3.644545e-01 | 0.438 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 3.644545e-01 | 0.438 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 3.647648e-01 | 0.438 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 3.647648e-01 | 0.438 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 3.647648e-01 | 0.438 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 3.647648e-01 | 0.438 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 3.707506e-01 | 0.431 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 3.707506e-01 | 0.431 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 3.707506e-01 | 0.431 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 3.707506e-01 | 0.431 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 3.707506e-01 | 0.431 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 3.707506e-01 | 0.431 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 3.712006e-01 | 0.430 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 3.712006e-01 | 0.430 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 3.766805e-01 | 0.424 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 3.766805e-01 | 0.424 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 3.774963e-01 | 0.423 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 3.825548e-01 | 0.417 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 3.825548e-01 | 0.417 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 3.831495e-01 | 0.417 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 3.851399e-01 | 0.414 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 3.876832e-01 | 0.412 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 3.883741e-01 | 0.411 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 3.883741e-01 | 0.411 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 3.883741e-01 | 0.411 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 3.883741e-01 | 0.411 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 3.902241e-01 | 0.409 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 3.912644e-01 | 0.408 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 3.941389e-01 | 0.404 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 3.941389e-01 | 0.404 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 3.941389e-01 | 0.404 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 3.941389e-01 | 0.404 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 3.946275e-01 | 0.404 | 0 | 0 |
| Immune System | R-HSA-168256 | 3.954209e-01 | 0.403 | 1 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 3.978901e-01 | 0.400 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 3.998498e-01 | 0.398 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 3.998498e-01 | 0.398 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 3.998498e-01 | 0.398 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 3.998498e-01 | 0.398 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 3.998498e-01 | 0.398 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 3.998498e-01 | 0.398 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 3.998498e-01 | 0.398 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 3.998498e-01 | 0.398 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 3.998498e-01 | 0.398 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 3.998498e-01 | 0.398 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 4.004013e-01 | 0.398 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 4.064161e-01 | 0.391 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 4.064161e-01 | 0.391 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 4.166634e-01 | 0.380 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 4.166634e-01 | 0.380 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 4.166634e-01 | 0.380 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 4.221633e-01 | 0.375 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 4.221633e-01 | 0.375 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 4.276117e-01 | 0.369 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 4.276117e-01 | 0.369 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 4.276117e-01 | 0.369 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 4.330090e-01 | 0.364 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 4.330090e-01 | 0.364 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 4.330090e-01 | 0.364 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 4.337120e-01 | 0.363 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 4.383558e-01 | 0.358 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 4.383558e-01 | 0.358 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.383558e-01 | 0.358 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 4.401046e-01 | 0.356 | 1 | 1 |
| Macroautophagy | R-HSA-1632852 | 4.401046e-01 | 0.356 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 4.436525e-01 | 0.353 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 4.436525e-01 | 0.353 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 4.451865e-01 | 0.351 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 4.453415e-01 | 0.351 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 4.463877e-01 | 0.350 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 4.464580e-01 | 0.350 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 4.464580e-01 | 0.350 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 4.488995e-01 | 0.348 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 4.488995e-01 | 0.348 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 4.488995e-01 | 0.348 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 4.496198e-01 | 0.347 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 4.527714e-01 | 0.344 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 4.536894e-01 | 0.343 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 4.540974e-01 | 0.343 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 4.540974e-01 | 0.343 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 4.540974e-01 | 0.343 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 4.540974e-01 | 0.343 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 4.540974e-01 | 0.343 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 4.540974e-01 | 0.343 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 4.592466e-01 | 0.338 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 4.592466e-01 | 0.338 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 4.592466e-01 | 0.338 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 4.603627e-01 | 0.337 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 4.621649e-01 | 0.335 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 4.643475e-01 | 0.333 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 4.643475e-01 | 0.333 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 4.643475e-01 | 0.333 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 4.652753e-01 | 0.332 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 4.673453e-01 | 0.330 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 4.683752e-01 | 0.329 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 4.694007e-01 | 0.328 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 4.694007e-01 | 0.328 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 4.694007e-01 | 0.328 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 4.694007e-01 | 0.328 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 4.694007e-01 | 0.328 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 4.694007e-01 | 0.328 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 4.694007e-01 | 0.328 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 4.714644e-01 | 0.327 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 4.716233e-01 | 0.326 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 4.721839e-01 | 0.326 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 4.744064e-01 | 0.324 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.744064e-01 | 0.324 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 4.744064e-01 | 0.324 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 4.744064e-01 | 0.324 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 4.745430e-01 | 0.324 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 4.776109e-01 | 0.321 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 4.793653e-01 | 0.319 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 4.797779e-01 | 0.319 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 4.806679e-01 | 0.318 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 4.837141e-01 | 0.315 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 4.842777e-01 | 0.315 | 1 | 1 |
| tRNA processing in the nucleus | R-HSA-6784531 | 4.842777e-01 | 0.315 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 4.842777e-01 | 0.315 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 4.842777e-01 | 0.315 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 4.891440e-01 | 0.311 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 4.897735e-01 | 0.310 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 4.927866e-01 | 0.307 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 4.987402e-01 | 0.302 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 5.017589e-01 | 0.300 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 5.034709e-01 | 0.298 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 5.081573e-01 | 0.294 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 5.081573e-01 | 0.294 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 5.120258e-01 | 0.291 | 1 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 5.124771e-01 | 0.290 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 5.127998e-01 | 0.290 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 5.127998e-01 | 0.290 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.127998e-01 | 0.290 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 5.127998e-01 | 0.290 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 5.127998e-01 | 0.290 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 5.219545e-01 | 0.282 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.219545e-01 | 0.282 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 5.219545e-01 | 0.282 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 5.219545e-01 | 0.282 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 5.232223e-01 | 0.281 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 5.264675e-01 | 0.279 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 5.264675e-01 | 0.279 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 5.264675e-01 | 0.279 | 0 | 0 |
| M Phase | R-HSA-68886 | 5.294197e-01 | 0.276 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 5.309382e-01 | 0.275 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 5.309382e-01 | 0.275 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 5.337772e-01 | 0.273 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 5.353670e-01 | 0.271 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 5.353670e-01 | 0.271 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 5.397543e-01 | 0.268 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 5.397543e-01 | 0.268 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 5.441003e-01 | 0.264 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 5.441003e-01 | 0.264 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 5.450698e-01 | 0.264 | 1 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 5.484057e-01 | 0.261 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 5.568955e-01 | 0.254 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 5.568955e-01 | 0.254 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 5.568955e-01 | 0.254 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 5.568955e-01 | 0.254 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 5.568955e-01 | 0.254 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 5.610808e-01 | 0.251 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 5.652268e-01 | 0.248 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 5.652268e-01 | 0.248 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 5.693338e-01 | 0.245 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 5.693338e-01 | 0.245 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 5.693338e-01 | 0.245 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 5.724661e-01 | 0.242 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 5.778009e-01 | 0.238 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 5.814253e-01 | 0.236 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 5.814253e-01 | 0.236 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 5.830873e-01 | 0.234 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 5.853803e-01 | 0.233 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 5.853803e-01 | 0.233 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 5.931794e-01 | 0.227 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 5.970241e-01 | 0.224 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 6.008327e-01 | 0.221 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 6.046055e-01 | 0.219 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 6.083429e-01 | 0.216 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 6.120453e-01 | 0.213 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 6.120453e-01 | 0.213 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 6.137869e-01 | 0.212 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 6.157128e-01 | 0.211 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 6.193459e-01 | 0.208 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 6.265101e-01 | 0.203 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 6.300417e-01 | 0.201 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 6.300417e-01 | 0.201 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 6.335402e-01 | 0.198 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 6.335402e-01 | 0.198 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 6.404390e-01 | 0.194 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 6.404390e-01 | 0.194 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 6.406998e-01 | 0.193 | 1 | 0 |
| Signaling by FGFR | R-HSA-190236 | 6.438398e-01 | 0.191 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 6.450773e-01 | 0.190 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 6.461034e-01 | 0.190 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 6.472086e-01 | 0.189 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 6.505458e-01 | 0.187 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 6.505458e-01 | 0.187 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 6.538517e-01 | 0.185 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 6.571265e-01 | 0.182 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 6.571265e-01 | 0.182 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 6.571265e-01 | 0.182 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 6.571265e-01 | 0.182 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 6.603705e-01 | 0.180 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 6.635840e-01 | 0.178 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 6.635840e-01 | 0.178 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 6.683755e-01 | 0.175 | 1 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 6.709665e-01 | 0.173 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 6.761387e-01 | 0.170 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 6.786725e-01 | 0.168 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 6.792040e-01 | 0.168 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 6.792040e-01 | 0.168 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 6.809026e-01 | 0.167 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 6.892847e-01 | 0.162 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 6.911795e-01 | 0.160 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 6.911795e-01 | 0.160 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 6.911795e-01 | 0.160 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 6.911795e-01 | 0.160 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 6.941033e-01 | 0.159 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 6.969996e-01 | 0.157 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 7.055261e-01 | 0.151 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 7.083149e-01 | 0.150 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 7.083149e-01 | 0.150 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 7.110775e-01 | 0.148 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 7.138142e-01 | 0.146 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 7.218705e-01 | 0.142 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 7.218705e-01 | 0.142 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 7.297014e-01 | 0.137 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 7.369613e-01 | 0.133 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 7.398030e-01 | 0.131 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 7.523829e-01 | 0.124 | 1 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 7.542563e-01 | 0.122 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 7.576608e-01 | 0.121 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 7.679118e-01 | 0.115 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 7.701132e-01 | 0.113 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 7.744541e-01 | 0.111 | 1 | 1 |
| Parasite infection | R-HSA-9664407 | 7.744541e-01 | 0.111 | 1 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 7.744541e-01 | 0.111 | 1 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 7.787188e-01 | 0.109 | 1 | 0 |
| Leishmania infection | R-HSA-9658195 | 7.787188e-01 | 0.109 | 1 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 7.802857e-01 | 0.108 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 7.890157e-01 | 0.103 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 7.910182e-01 | 0.102 | 0 | 0 |
| S Phase | R-HSA-69242 | 7.930018e-01 | 0.101 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 8.007511e-01 | 0.097 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 8.007511e-01 | 0.097 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 8.026429e-01 | 0.095 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 8.100335e-01 | 0.091 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 8.118378e-01 | 0.091 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 8.118378e-01 | 0.091 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 8.223114e-01 | 0.085 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 8.223114e-01 | 0.085 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 8.273289e-01 | 0.082 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.338007e-01 | 0.079 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 8.369456e-01 | 0.077 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 8.384958e-01 | 0.076 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 8.384958e-01 | 0.076 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 8.489449e-01 | 0.071 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 8.573649e-01 | 0.067 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 8.600666e-01 | 0.065 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 8.657688e-01 | 0.063 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 8.666005e-01 | 0.062 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 8.666005e-01 | 0.062 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 8.703745e-01 | 0.060 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 8.703745e-01 | 0.060 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 8.752418e-01 | 0.058 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 8.764300e-01 | 0.057 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 8.776070e-01 | 0.057 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 8.787728e-01 | 0.056 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 8.793979e-01 | 0.056 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 8.797538e-01 | 0.056 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 8.959938e-01 | 0.048 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 8.967401e-01 | 0.047 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.051097e-01 | 0.043 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.072937e-01 | 0.042 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 9.107823e-01 | 0.041 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.133129e-01 | 0.039 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.212442e-01 | 0.036 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.234799e-01 | 0.035 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.265873e-01 | 0.033 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 9.277638e-01 | 0.033 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 9.291381e-01 | 0.032 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.331072e-01 | 0.030 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.411476e-01 | 0.026 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 9.456529e-01 | 0.024 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.474902e-01 | 0.023 | 1 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.503534e-01 | 0.022 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.802798e-01 | 0.009 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.818801e-01 | 0.008 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.833385e-01 | 0.007 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.833385e-01 | 0.007 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.855950e-01 | 0.006 | 0 | 0 |
| Translation | R-HSA-72766 | 9.865414e-01 | 0.006 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.868379e-01 | 0.006 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.904613e-01 | 0.004 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.941859e-01 | 0.003 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.978763e-01 | 0.001 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 9.995889e-01 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.999947e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | 0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.411093e-13 | 12.850 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 5.663019e-10 | 9.247 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.213436e-09 | 8.916 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.213436e-09 | 8.916 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.213436e-09 | 8.916 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 8.055009e-09 | 8.094 | 1 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 6.497275e-08 | 7.187 | 1 | 1 |
| Activation of BH3-only proteins | R-HSA-114452 | 9.247259e-08 | 7.034 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 1.137026e-07 | 6.944 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 1.821479e-07 | 6.740 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 2.246567e-07 | 6.648 | 1 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 3.531338e-07 | 6.452 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 6.589474e-07 | 6.181 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 6.702224e-07 | 6.174 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 6.232201e-07 | 6.205 | 1 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 7.850094e-07 | 6.105 | 1 | 1 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.377619e-06 | 5.861 | 1 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.365144e-06 | 5.865 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.622492e-06 | 5.790 | 1 | 0 |
| Glycolysis | R-HSA-70171 | 1.972538e-06 | 5.705 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 2.222241e-06 | 5.653 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 4.122209e-06 | 5.385 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 4.557178e-06 | 5.341 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 7.414166e-06 | 5.130 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 8.048435e-06 | 5.094 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 8.048435e-06 | 5.094 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.557181e-06 | 5.020 | 1 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.049131e-05 | 4.979 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.171747e-05 | 4.931 | 1 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.864915e-05 | 4.729 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 2.015574e-05 | 4.696 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 2.072295e-05 | 4.684 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.176139e-05 | 4.662 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 2.209964e-05 | 4.656 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 3.368039e-05 | 4.473 | 1 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 3.674397e-05 | 4.435 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 4.294162e-05 | 4.367 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 4.155420e-05 | 4.381 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 4.294162e-05 | 4.367 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 4.101103e-05 | 4.387 | 1 | 0 |
| G2/M Transition | R-HSA-69275 | 4.264904e-05 | 4.370 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 4.621731e-05 | 4.335 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 4.663043e-05 | 4.331 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 5.192212e-05 | 4.285 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 5.627149e-05 | 4.250 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 6.556108e-05 | 4.183 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 6.286048e-05 | 4.202 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 6.272814e-05 | 4.203 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 7.802341e-05 | 4.108 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 8.619341e-05 | 4.065 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.217568e-04 | 3.915 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 1.446590e-04 | 3.840 | 1 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.847501e-04 | 3.733 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.918122e-04 | 3.717 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 1.961539e-04 | 3.707 | 1 | 1 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.196254e-04 | 3.658 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.196254e-04 | 3.658 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.196254e-04 | 3.658 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.196254e-04 | 3.658 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 2.033835e-04 | 3.692 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 2.388368e-04 | 3.622 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 2.593511e-04 | 3.586 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.776244e-04 | 3.557 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 2.810685e-04 | 3.551 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 3.029150e-04 | 3.519 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 3.147808e-04 | 3.502 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 3.926312e-04 | 3.406 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 4.059062e-04 | 3.392 | 1 | 0 |
| Immune System | R-HSA-168256 | 4.199709e-04 | 3.377 | 1 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 4.275573e-04 | 3.369 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 4.375516e-04 | 3.359 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 4.410743e-04 | 3.355 | 1 | 0 |
| Apoptosis | R-HSA-109581 | 4.642350e-04 | 3.333 | 1 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 5.381991e-04 | 3.269 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 5.483202e-04 | 3.261 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 5.763081e-04 | 3.239 | 0 | 0 |
| Disease | R-HSA-1643685 | 6.750648e-04 | 3.171 | 1 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 6.838906e-04 | 3.165 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 7.152160e-04 | 3.146 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 7.185415e-04 | 3.144 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 8.059839e-04 | 3.094 | 1 | 1 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 8.059839e-04 | 3.094 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 8.263119e-04 | 3.083 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 8.537949e-04 | 3.069 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.379298e-04 | 3.028 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 9.443434e-04 | 3.025 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.020479e-03 | 2.991 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.030693e-03 | 2.987 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 1.172367e-03 | 2.931 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.083322e-03 | 2.965 | 1 | 1 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.138180e-03 | 2.944 | 1 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.208954e-03 | 2.918 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.278565e-03 | 2.893 | 1 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 1.298618e-03 | 2.887 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.298618e-03 | 2.887 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.402025e-03 | 2.853 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 1.429773e-03 | 2.845 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.511043e-03 | 2.821 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.511043e-03 | 2.821 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.622029e-03 | 2.790 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.625831e-03 | 2.789 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 1.513235e-03 | 2.820 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.746546e-03 | 2.758 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.576555e-03 | 2.802 | 1 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.579924e-03 | 2.801 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.907942e-03 | 2.719 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.053297e-03 | 2.688 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 2.053297e-03 | 2.688 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 2.177217e-03 | 2.662 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.268297e-03 | 2.644 | 0 | 0 |
| M Phase | R-HSA-68886 | 2.357987e-03 | 2.627 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.449285e-03 | 2.611 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 2.559974e-03 | 2.592 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 2.731923e-03 | 2.564 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 2.804072e-03 | 2.552 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.804072e-03 | 2.552 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 3.114269e-03 | 2.507 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 3.423041e-03 | 2.466 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 3.049987e-03 | 2.516 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 3.375797e-03 | 2.472 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 3.605810e-03 | 2.443 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 3.171599e-03 | 2.499 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 3.171599e-03 | 2.499 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 3.355411e-03 | 2.474 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 3.701503e-03 | 2.432 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 3.701503e-03 | 2.432 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 3.701503e-03 | 2.432 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 3.713529e-03 | 2.430 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 3.849709e-03 | 2.415 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 3.930567e-03 | 2.406 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 4.540367e-03 | 2.343 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 4.965075e-03 | 2.304 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 5.106687e-03 | 2.292 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 5.407163e-03 | 2.267 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 5.458538e-03 | 2.263 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 5.458538e-03 | 2.263 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 5.548838e-03 | 2.256 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.639285e-03 | 2.249 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.639285e-03 | 2.249 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 6.454398e-03 | 2.190 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 6.454398e-03 | 2.190 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 6.207748e-03 | 2.207 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 6.454398e-03 | 2.190 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 5.918969e-03 | 2.228 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 5.918969e-03 | 2.228 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 5.666357e-03 | 2.247 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 6.454398e-03 | 2.190 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 7.051544e-03 | 2.152 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 5.808739e-03 | 2.236 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 5.813458e-03 | 2.236 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 6.207748e-03 | 2.207 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 7.340028e-03 | 2.134 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 7.526350e-03 | 2.123 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 7.526350e-03 | 2.123 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 7.526350e-03 | 2.123 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 7.526350e-03 | 2.123 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 7.585470e-03 | 2.120 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 8.076911e-03 | 2.093 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 8.494109e-03 | 2.071 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 8.620760e-03 | 2.064 | 1 | 1 |
| vRNP Assembly | R-HSA-192905 | 8.672822e-03 | 2.062 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 8.672822e-03 | 2.062 | 0 | 0 |
| Drug resistance of FLT3 mutants | R-HSA-9702506 | 9.825653e-03 | 2.008 | 0 | 0 |
| FLT3 mutants bind TKIs | R-HSA-9702509 | 9.825653e-03 | 2.008 | 0 | 0 |
| ponatinib-resistant FLT3 mutants | R-HSA-9702614 | 9.825653e-03 | 2.008 | 0 | 0 |
| KW2449-resistant FLT3 mutants | R-HSA-9702569 | 9.825653e-03 | 2.008 | 0 | 0 |
| lestaurtinib-resistant FLT3 mutants | R-HSA-9702596 | 9.825653e-03 | 2.008 | 0 | 0 |
| linifanib-resistant FLT3 mutants | R-HSA-9702998 | 9.825653e-03 | 2.008 | 0 | 0 |
| sunitinib-resistant FLT3 mutants | R-HSA-9702632 | 9.825653e-03 | 2.008 | 0 | 0 |
| pexidartinib-resistant FLT3 mutants | R-HSA-9702605 | 9.825653e-03 | 2.008 | 0 | 0 |
| sorafenib-resistant FLT3 mutants | R-HSA-9702624 | 9.825653e-03 | 2.008 | 0 | 0 |
| tamatinib-resistant FLT3 mutants | R-HSA-9703009 | 9.825653e-03 | 2.008 | 0 | 0 |
| quizartinib-resistant FLT3 mutants | R-HSA-9702620 | 9.825653e-03 | 2.008 | 0 | 0 |
| gilteritinib-resistant FLT3 mutants | R-HSA-9702590 | 9.825653e-03 | 2.008 | 0 | 0 |
| crenolanib-resistant FLT3 mutants | R-HSA-9702581 | 9.825653e-03 | 2.008 | 0 | 0 |
| tandutinib-resistant FLT3 mutants | R-HSA-9702636 | 9.825653e-03 | 2.008 | 0 | 0 |
| midostaurin-resistant FLT3 mutants | R-HSA-9702600 | 9.825653e-03 | 2.008 | 0 | 0 |
| semaxanib-resistant FLT3 mutants | R-HSA-9702577 | 9.825653e-03 | 2.008 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 1.037901e-02 | 1.984 | 1 | 0 |
| HSF1 activation | R-HSA-3371511 | 9.185619e-03 | 2.037 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 1.053479e-02 | 1.977 | 1 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 1.053479e-02 | 1.977 | 1 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 9.892265e-03 | 2.005 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.138269e-02 | 1.944 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 9.185619e-03 | 2.037 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.027680e-02 | 1.988 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 9.836746e-03 | 2.007 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.171113e-02 | 1.931 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.041227e-02 | 1.982 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 8.826601e-03 | 2.054 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.302432e-02 | 1.885 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.390671e-02 | 1.857 | 1 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.397327e-02 | 1.855 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.410308e-02 | 1.851 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.523805e-02 | 1.817 | 1 | 0 |
| DAP12 interactions | R-HSA-2172127 | 1.523805e-02 | 1.817 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.546957e-02 | 1.811 | 1 | 1 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.546957e-02 | 1.811 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.562187e-02 | 1.806 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.616172e-02 | 1.792 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 1.765117e-02 | 1.753 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 1.850012e-02 | 1.733 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.865742e-02 | 1.729 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 1.865742e-02 | 1.729 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 1.898402e-02 | 1.722 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 1.903620e-02 | 1.720 | 0 | 0 |
| Protein folding | R-HSA-391251 | 1.903620e-02 | 1.720 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.977866e-02 | 1.704 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 2.026511e-02 | 1.693 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.034618e-02 | 1.692 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.034618e-02 | 1.692 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.034618e-02 | 1.692 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 2.042824e-02 | 1.690 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 2.042859e-02 | 1.690 | 1 | 1 |
| Parasite infection | R-HSA-9664407 | 2.042859e-02 | 1.690 | 1 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 2.042859e-02 | 1.690 | 1 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 2.095500e-02 | 1.679 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.209632e-02 | 1.656 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.209632e-02 | 1.656 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.209632e-02 | 1.656 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 2.211972e-02 | 1.655 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 2.220863e-02 | 1.653 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 2.919006e-02 | 1.535 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.577533e-02 | 1.589 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.770157e-02 | 1.557 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.770157e-02 | 1.557 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 3.172103e-02 | 1.499 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.172103e-02 | 1.499 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 2.453559e-02 | 1.610 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.979864e-02 | 1.526 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 3.381173e-02 | 1.471 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.189648e-02 | 1.496 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 3.357513e-02 | 1.474 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 2.714846e-02 | 1.566 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 2.361883e-02 | 1.627 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 2.792081e-02 | 1.554 | 1 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.390648e-02 | 1.621 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.577533e-02 | 1.589 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 3.043394e-02 | 1.517 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 2.568585e-02 | 1.590 | 1 | 1 |
| Ribavirin ADME | R-HSA-9755088 | 2.968389e-02 | 1.527 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 2.425800e-02 | 1.615 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.997200e-02 | 1.523 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.518801e-02 | 1.599 | 0 | 0 |
| Kinesins | R-HSA-983189 | 3.043394e-02 | 1.517 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 3.381173e-02 | 1.471 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 3.053838e-02 | 1.515 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 3.107831e-02 | 1.508 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.770157e-02 | 1.557 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 3.381173e-02 | 1.471 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 3.381173e-02 | 1.471 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.107614e-02 | 1.508 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.107614e-02 | 1.508 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 2.316184e-02 | 1.635 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 3.529388e-02 | 1.452 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 3.529759e-02 | 1.452 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 3.595476e-02 | 1.444 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 3.595476e-02 | 1.444 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 3.595476e-02 | 1.444 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 3.595476e-02 | 1.444 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 3.708478e-02 | 1.431 | 1 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 3.778559e-02 | 1.423 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 3.814889e-02 | 1.419 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 3.814889e-02 | 1.419 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 3.814889e-02 | 1.419 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 3.873067e-02 | 1.412 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 3.873067e-02 | 1.412 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 3.873067e-02 | 1.412 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 3.873067e-02 | 1.412 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 3.873067e-02 | 1.412 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 3.873067e-02 | 1.412 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 3.873067e-02 | 1.412 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 3.873067e-02 | 1.412 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 3.873067e-02 | 1.412 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 3.873067e-02 | 1.412 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 3.873067e-02 | 1.412 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.873067e-02 | 1.412 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 3.985071e-02 | 1.400 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 3.995100e-02 | 1.398 | 1 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 4.039294e-02 | 1.394 | 1 | 1 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 4.039294e-02 | 1.394 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 4.268572e-02 | 1.370 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 4.268572e-02 | 1.370 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 4.268572e-02 | 1.370 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 4.268572e-02 | 1.370 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 4.417704e-02 | 1.355 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 4.431185e-02 | 1.353 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 4.572689e-02 | 1.340 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 4.741285e-02 | 1.324 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 4.741285e-02 | 1.324 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 4.778756e-02 | 1.321 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 4.817811e-02 | 1.317 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 4.817811e-02 | 1.317 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 4.817811e-02 | 1.317 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 4.823610e-02 | 1.317 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 4.837818e-02 | 1.315 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 4.982068e-02 | 1.303 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 4.984494e-02 | 1.302 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 4.984494e-02 | 1.302 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 4.984494e-02 | 1.302 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 5.231843e-02 | 1.281 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 5.232122e-02 | 1.281 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 5.427423e-02 | 1.265 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 5.734357e-02 | 1.242 | 1 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 5.734357e-02 | 1.242 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 5.740202e-02 | 1.241 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 5.753327e-02 | 1.240 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 5.753327e-02 | 1.240 | 0 | 0 |
| Nucleotide catabolism defects | R-HSA-9735786 | 5.753327e-02 | 1.240 | 0 | 0 |
| Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine | R-HSA-9735763 | 5.753327e-02 | 1.240 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 5.753327e-02 | 1.240 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 5.753327e-02 | 1.240 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 6.002661e-02 | 1.222 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 6.679705e-02 | 1.175 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 6.679705e-02 | 1.175 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 7.597035e-02 | 1.119 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 8.505404e-02 | 1.070 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 9.404898e-02 | 1.027 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 9.404898e-02 | 1.027 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 1.029560e-01 | 0.987 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.029560e-01 | 0.987 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.029560e-01 | 0.987 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 1.205099e-01 | 0.919 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.205099e-01 | 0.919 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 6.264672e-02 | 1.203 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 6.264672e-02 | 1.203 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 8.217697e-02 | 1.085 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.029560e-01 | 0.987 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.205099e-01 | 0.919 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.205099e-01 | 0.919 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 6.804707e-02 | 1.167 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 9.404898e-02 | 1.027 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.117761e-01 | 0.952 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 8.806066e-02 | 1.055 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 7.597035e-02 | 1.119 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 6.314265e-02 | 1.200 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 9.711193e-02 | 1.013 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 6.679705e-02 | 1.175 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 7.597035e-02 | 1.119 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 7.597035e-02 | 1.119 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 6.264672e-02 | 1.203 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 8.286618e-02 | 1.082 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 6.679705e-02 | 1.175 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.117761e-01 | 0.952 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 7.359506e-02 | 1.133 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 9.404898e-02 | 1.027 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.117761e-01 | 0.952 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.205099e-01 | 0.919 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 8.123014e-02 | 1.090 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 6.291826e-02 | 1.201 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 6.679705e-02 | 1.175 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 1.117761e-01 | 0.952 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.159433e-01 | 0.936 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 8.510318e-02 | 1.070 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 7.597035e-02 | 1.119 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 7.597035e-02 | 1.119 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 8.505404e-02 | 1.070 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 9.404898e-02 | 1.027 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 1.117761e-01 | 0.952 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.205099e-01 | 0.919 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 7.928294e-02 | 1.101 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 9.037208e-02 | 1.044 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 8.510318e-02 | 1.070 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 9.711193e-02 | 1.013 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 9.404898e-02 | 1.027 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 1.127427e-01 | 0.948 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 8.217697e-02 | 1.085 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 1.029560e-01 | 0.987 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 6.717127e-02 | 1.173 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.122883e-01 | 0.950 | 1 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.205099e-01 | 0.919 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.711193e-02 | 1.013 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 7.928294e-02 | 1.101 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 1.029560e-01 | 0.987 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.144821e-01 | 0.941 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 7.642199e-02 | 1.117 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 9.189046e-02 | 1.037 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.104853e-02 | 1.041 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.064135e-01 | 0.973 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 9.815129e-02 | 1.008 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 7.246236e-02 | 1.140 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 8.300321e-02 | 1.081 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 8.188892e-02 | 1.087 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 6.860279e-02 | 1.164 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 9.406590e-02 | 1.027 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 7.642199e-02 | 1.117 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.224129e-01 | 0.912 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 1.251766e-01 | 0.902 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.251766e-01 | 0.902 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.291585e-01 | 0.889 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 1.291585e-01 | 0.889 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 1.291585e-01 | 0.889 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 1.291585e-01 | 0.889 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 1.291585e-01 | 0.889 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 1.304094e-01 | 0.885 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.322768e-01 | 0.879 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 1.322768e-01 | 0.879 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.356045e-01 | 0.868 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.356045e-01 | 0.868 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 1.377224e-01 | 0.861 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.377224e-01 | 0.861 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 1.377224e-01 | 0.861 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.413759e-01 | 0.850 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.450332e-01 | 0.839 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.456968e-01 | 0.837 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.462027e-01 | 0.835 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 1.462027e-01 | 0.835 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 1.462027e-01 | 0.835 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.462027e-01 | 0.835 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 1.462027e-01 | 0.835 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 1.462027e-01 | 0.835 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.462027e-01 | 0.835 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.462027e-01 | 0.835 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.462027e-01 | 0.835 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 1.462027e-01 | 0.835 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 1.462027e-01 | 0.835 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.478952e-01 | 0.830 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 1.490951e-01 | 0.827 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 1.525094e-01 | 0.817 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 1.525094e-01 | 0.817 | 1 | 1 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.546002e-01 | 0.811 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.546002e-01 | 0.811 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 1.546002e-01 | 0.811 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 1.546002e-01 | 0.811 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 1.546002e-01 | 0.811 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 1.546002e-01 | 0.811 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.568837e-01 | 0.804 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 1.570899e-01 | 0.804 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 1.593836e-01 | 0.798 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 1.629155e-01 | 0.788 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 1.629155e-01 | 0.788 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 1.629155e-01 | 0.788 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.629155e-01 | 0.788 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.629155e-01 | 0.788 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 1.639793e-01 | 0.785 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.711496e-01 | 0.767 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.711496e-01 | 0.767 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 1.711496e-01 | 0.767 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.711496e-01 | 0.767 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 1.711496e-01 | 0.767 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 1.711496e-01 | 0.767 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 1.711496e-01 | 0.767 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.711496e-01 | 0.767 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.732967e-01 | 0.761 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.732967e-01 | 0.761 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 1.760358e-01 | 0.754 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.768059e-01 | 0.753 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.793031e-01 | 0.746 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.793031e-01 | 0.746 | 1 | 1 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 1.793031e-01 | 0.746 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 1.793031e-01 | 0.746 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 1.793031e-01 | 0.746 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.793031e-01 | 0.746 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 1.793031e-01 | 0.746 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.838574e-01 | 0.736 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 1.838574e-01 | 0.736 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 1.873770e-01 | 0.727 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.873770e-01 | 0.727 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.873986e-01 | 0.727 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.873986e-01 | 0.727 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 1.873986e-01 | 0.727 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.909493e-01 | 0.719 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 1.932547e-01 | 0.714 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 1.945091e-01 | 0.711 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.953719e-01 | 0.709 | 1 | 1 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 1.953719e-01 | 0.709 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 1.953719e-01 | 0.709 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 2.016539e-01 | 0.695 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.032887e-01 | 0.692 | 0 | 0 |
| PKA activation | R-HSA-163615 | 2.032887e-01 | 0.692 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.032887e-01 | 0.692 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.032887e-01 | 0.692 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 2.088288e-01 | 0.680 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.088288e-01 | 0.680 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 2.088288e-01 | 0.680 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 2.111280e-01 | 0.675 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.111280e-01 | 0.675 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 2.111280e-01 | 0.675 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 2.111280e-01 | 0.675 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 2.111280e-01 | 0.675 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 2.124263e-01 | 0.673 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 2.160299e-01 | 0.665 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 2.188907e-01 | 0.660 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.188907e-01 | 0.660 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.188907e-01 | 0.660 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 2.265775e-01 | 0.645 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 2.265775e-01 | 0.645 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 2.285149e-01 | 0.641 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.341891e-01 | 0.630 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 2.341891e-01 | 0.630 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.341891e-01 | 0.630 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.341891e-01 | 0.630 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 2.341891e-01 | 0.630 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.341891e-01 | 0.630 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.377542e-01 | 0.624 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.377542e-01 | 0.624 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 2.417263e-01 | 0.617 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.417263e-01 | 0.617 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 2.445198e-01 | 0.612 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 2.475452e-01 | 0.606 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 2.486178e-01 | 0.604 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 2.486628e-01 | 0.604 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 2.491897e-01 | 0.603 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 2.491897e-01 | 0.603 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.491897e-01 | 0.603 | 1 | 1 |
| Transmission across Chemical Synapses | R-HSA-112315 | 2.521224e-01 | 0.598 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 2.524035e-01 | 0.598 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 2.565802e-01 | 0.591 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 2.565802e-01 | 0.591 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 2.565802e-01 | 0.591 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.638983e-01 | 0.579 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 2.638983e-01 | 0.579 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 2.638983e-01 | 0.579 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 2.638983e-01 | 0.579 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 2.638983e-01 | 0.579 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.638983e-01 | 0.579 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.711449e-01 | 0.567 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 2.778056e-01 | 0.556 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.783206e-01 | 0.555 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.783206e-01 | 0.555 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 2.783206e-01 | 0.555 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 2.783206e-01 | 0.555 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 2.783206e-01 | 0.555 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 2.783206e-01 | 0.555 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 2.854260e-01 | 0.545 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 2.854260e-01 | 0.545 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 2.854260e-01 | 0.545 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 2.854260e-01 | 0.545 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 2.854260e-01 | 0.545 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 2.854260e-01 | 0.545 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.887263e-01 | 0.540 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 2.909391e-01 | 0.536 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 2.923629e-01 | 0.534 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 2.923629e-01 | 0.534 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 2.924620e-01 | 0.534 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 2.924620e-01 | 0.534 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 2.924620e-01 | 0.534 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 2.924620e-01 | 0.534 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 2.924620e-01 | 0.534 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 2.949722e-01 | 0.530 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 2.949722e-01 | 0.530 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 2.994291e-01 | 0.524 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.994291e-01 | 0.524 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 2.994291e-01 | 0.524 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 2.996289e-01 | 0.523 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 3.063280e-01 | 0.514 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 3.063280e-01 | 0.514 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 3.063280e-01 | 0.514 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 3.063280e-01 | 0.514 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 3.063280e-01 | 0.514 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 3.068831e-01 | 0.513 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 3.068831e-01 | 0.513 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 3.110771e-01 | 0.507 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 3.131594e-01 | 0.504 | 1 | 1 |
| RSV-host interactions | R-HSA-9833110 | 3.177373e-01 | 0.498 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 3.199239e-01 | 0.495 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 3.199239e-01 | 0.495 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 3.199239e-01 | 0.495 | 1 | 1 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 3.199239e-01 | 0.495 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.199239e-01 | 0.495 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 3.199239e-01 | 0.495 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 3.199239e-01 | 0.495 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 3.199239e-01 | 0.495 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 3.199239e-01 | 0.495 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 3.199239e-01 | 0.495 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 3.249523e-01 | 0.488 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 3.266223e-01 | 0.486 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 3.266223e-01 | 0.486 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.266223e-01 | 0.486 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 3.280817e-01 | 0.484 | 1 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 3.332550e-01 | 0.477 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 3.398229e-01 | 0.469 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.398229e-01 | 0.469 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 3.398229e-01 | 0.469 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 3.398229e-01 | 0.469 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 3.463264e-01 | 0.461 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 3.463264e-01 | 0.461 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 3.527663e-01 | 0.453 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.527663e-01 | 0.453 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 3.527663e-01 | 0.453 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 3.571515e-01 | 0.447 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 3.591431e-01 | 0.445 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 3.591431e-01 | 0.445 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 3.591431e-01 | 0.445 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 3.591431e-01 | 0.445 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 3.591431e-01 | 0.445 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 3.642363e-01 | 0.439 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 3.642363e-01 | 0.439 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 3.654575e-01 | 0.437 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 3.654575e-01 | 0.437 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 3.654575e-01 | 0.437 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 3.654575e-01 | 0.437 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 3.654575e-01 | 0.437 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 3.654575e-01 | 0.437 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 3.674818e-01 | 0.435 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 3.717101e-01 | 0.430 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 3.717101e-01 | 0.430 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 3.717101e-01 | 0.430 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 3.717101e-01 | 0.430 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.717101e-01 | 0.430 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 3.717101e-01 | 0.430 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 3.717101e-01 | 0.430 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 3.717101e-01 | 0.430 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 3.754990e-01 | 0.425 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 3.779014e-01 | 0.423 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 3.779014e-01 | 0.423 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 3.779014e-01 | 0.423 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 3.818164e-01 | 0.418 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 3.840321e-01 | 0.416 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 3.843870e-01 | 0.415 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 3.853083e-01 | 0.414 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 3.901028e-01 | 0.409 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 3.901028e-01 | 0.409 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 3.901028e-01 | 0.409 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 3.961140e-01 | 0.402 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 3.961140e-01 | 0.402 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 4.079604e-01 | 0.389 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 4.079604e-01 | 0.389 | 1 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 4.079604e-01 | 0.389 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 4.137967e-01 | 0.383 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 4.137967e-01 | 0.383 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 4.137967e-01 | 0.383 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 4.137967e-01 | 0.383 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 4.137967e-01 | 0.383 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 4.137967e-01 | 0.383 | 1 | 0 |
| Drug ADME | R-HSA-9748784 | 4.178587e-01 | 0.379 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 4.252983e-01 | 0.371 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 4.252983e-01 | 0.371 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 4.252983e-01 | 0.371 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 4.252983e-01 | 0.371 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 4.309647e-01 | 0.366 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 4.365756e-01 | 0.360 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 4.387034e-01 | 0.358 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 4.421316e-01 | 0.354 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 4.421316e-01 | 0.354 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 4.465662e-01 | 0.350 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 4.476330e-01 | 0.349 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 4.476330e-01 | 0.349 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 4.530806e-01 | 0.344 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 4.530806e-01 | 0.344 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 4.668955e-01 | 0.331 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 4.691050e-01 | 0.329 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 4.691050e-01 | 0.329 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 4.691050e-01 | 0.329 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 4.691050e-01 | 0.329 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 4.694709e-01 | 0.328 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 4.726973e-01 | 0.325 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 4.744784e-01 | 0.324 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 4.846628e-01 | 0.315 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 4.846628e-01 | 0.315 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 4.846628e-01 | 0.315 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 4.897474e-01 | 0.310 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 4.918064e-01 | 0.308 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 4.947821e-01 | 0.306 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 4.947821e-01 | 0.306 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 4.947821e-01 | 0.306 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 4.949491e-01 | 0.305 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 4.997675e-01 | 0.301 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 4.997675e-01 | 0.301 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 4.997675e-01 | 0.301 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 5.011978e-01 | 0.300 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 5.011978e-01 | 0.300 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 5.043036e-01 | 0.297 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.095920e-01 | 0.293 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 5.095920e-01 | 0.293 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 5.116273e-01 | 0.291 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 5.166021e-01 | 0.287 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 5.239704e-01 | 0.281 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 5.239704e-01 | 0.281 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 5.239704e-01 | 0.281 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 5.256935e-01 | 0.279 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.286694e-01 | 0.277 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 5.286694e-01 | 0.277 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 5.286694e-01 | 0.277 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 5.312066e-01 | 0.275 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.379298e-01 | 0.269 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 5.424919e-01 | 0.266 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 5.424919e-01 | 0.266 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 5.426888e-01 | 0.265 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 5.464581e-01 | 0.262 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 5.470093e-01 | 0.262 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 5.514823e-01 | 0.258 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 5.514823e-01 | 0.258 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 5.559115e-01 | 0.255 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 5.646398e-01 | 0.248 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 5.731976e-01 | 0.242 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 5.731976e-01 | 0.242 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 5.731976e-01 | 0.242 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 5.815883e-01 | 0.235 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 5.815883e-01 | 0.235 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 5.857219e-01 | 0.232 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 5.898150e-01 | 0.229 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 5.938678e-01 | 0.226 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 5.978809e-01 | 0.223 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 6.018546e-01 | 0.221 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.057893e-01 | 0.218 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 6.057893e-01 | 0.218 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 6.096853e-01 | 0.215 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 6.135430e-01 | 0.212 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 6.248904e-01 | 0.204 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 6.285988e-01 | 0.202 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 6.359066e-01 | 0.197 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 6.393999e-01 | 0.194 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 6.395067e-01 | 0.194 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 6.430715e-01 | 0.192 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 6.430715e-01 | 0.192 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 6.455040e-01 | 0.190 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 6.466012e-01 | 0.189 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 6.466012e-01 | 0.189 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 6.535570e-01 | 0.185 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 6.535570e-01 | 0.185 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 6.605948e-01 | 0.180 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 6.637363e-01 | 0.178 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 6.736184e-01 | 0.172 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 6.736184e-01 | 0.172 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 6.800456e-01 | 0.167 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 6.863470e-01 | 0.163 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 6.955685e-01 | 0.158 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 7.064911e-01 | 0.151 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 7.271344e-01 | 0.138 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 7.271344e-01 | 0.138 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 7.271344e-01 | 0.138 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 7.421338e-01 | 0.130 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 7.458584e-01 | 0.127 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 7.602701e-01 | 0.119 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 7.673300e-01 | 0.115 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 7.851625e-01 | 0.105 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 7.872939e-01 | 0.104 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 8.055546e-01 | 0.094 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 8.112884e-01 | 0.091 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 8.168541e-01 | 0.088 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 8.240221e-01 | 0.084 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.275008e-01 | 0.082 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 8.292145e-01 | 0.081 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 8.469839e-01 | 0.072 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.469839e-01 | 0.072 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 8.485051e-01 | 0.071 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 8.485051e-01 | 0.071 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 8.500114e-01 | 0.071 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 8.615375e-01 | 0.065 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 8.656290e-01 | 0.063 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 8.696004e-01 | 0.061 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 8.721830e-01 | 0.059 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 8.734551e-01 | 0.059 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 8.913461e-01 | 0.050 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 8.947611e-01 | 0.048 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 8.973612e-01 | 0.047 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.118239e-01 | 0.040 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.185615e-01 | 0.037 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.200228e-01 | 0.036 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 9.201791e-01 | 0.036 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.262982e-01 | 0.033 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.379626e-01 | 0.028 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.486967e-01 | 0.023 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.507204e-01 | 0.022 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.567654e-01 | 0.019 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.728140e-01 | 0.012 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.824019e-01 | 0.008 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.842578e-01 | 0.007 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.862019e-01 | 0.006 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.887369e-01 | 0.005 | 0 | 0 |
| Translation | R-HSA-72766 | 9.889634e-01 | 0.005 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.932723e-01 | 0.003 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.957645e-01 | 0.002 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.975518e-01 | 0.001 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.978454e-01 | 0.001 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 9.997471e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 9.997944e-01 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.999972e-01 | 0.000 | 0 | 0 |